WhatIsBrainFog.com - Drug-Supplement Interaction Reference
Printed from: whatisbrainfog.com/drug-interactions/
Drug-Supplement Interactions & Medication Audit
Check every supplement against your medications before starting. Review this chart with your physician or pharmacist.
75 supplement interactions · 19 fog-causing medications · 51 medication profiles with CYP data. Cross-check with Drugs.com, Examine.com, or your pharmacist.
How to use this page
- Taking a supplement? → Check Table 1 to see what medications it conflicts with
- On a medication? → Check Table 3 to see which supplements you need to time, adjust, or avoid
- Experiencing brain fog? → Check Table 2 to see if your medication is a known cause
- Typically, verify with your pharmacist before starting a new supplement on any prescription medication
Table 1: Supplement-Drug Interactions
| Supplement | Do NOT Combine With | Risk | Severity | Timing | Monitor |
|---|---|---|---|---|---|
| 5-HTP Verify → | SSRIs, SNRIs, MAOIs, Tramadol, Triptans | Serotonin syndrome - potentially fatal. Case report: serotonin syndrome from sertraline + 5-HTP supplement led to rhabdomyolysis and acute compartment syndrome PMC5580516 (case report: SSRI + 5-HTP → serotonin syndrome → rhabdomyolysis); PMC6184959 (serotonin toxicity review) | AVOID | Take evening, with food | Watch for agitation, rapid heartbeat, high temperature |
| St. John's Wort Verify → | SSRIs, birth control, blood thinners, cyclosporine | Potent CYP3A4 inducer (degree correlates with hyperforin content). Reduces drug levels of cyclosporine, birth control, anticoagulants. Also causes serotonin syndrome with SSRIs - sertraline and paroxetine most commonly reported PMC1874438 (clinical outcomes review); PMC2782080 (updated clinical observations); PMID 15260917 (pharmacokinetic interactions); PMC12420457 (SSRI interactions) | AVOID | Take with food. Wash out 2+ weeks | Monitor breakthrough bleeding, INR |
| Ginkgo Biloba Verify → | Blood thinners, NSAIDs | Increased bleeding risk. 2025 meta-analysis: OR 1.08 (p<0.001) for bleeding when combined with antiplatelets. Clopidogrel and aspirin showed highest interaction prevalence. However, controlled RCTs show less clear risk than case reports suggest PMID 40198642 (2025 comprehensive analysis, n=1985); PMID 21923430 (systematic review/meta-analysis); PMID 18214851 (antiplatelet interaction review) | HIGH | Take with food, morning/noon. Stop 2 weeks before surgery | Watch for unusual bruising |
| NAC Verify → | Nitroglycerin, activated charcoal | Forms S-nitroso-NAC with nitroglycerin - potentiates vasodilation and headache. Study: headache score tripled (3 vs 1), symptomatic hypotension in 7 vs 0 patients (p=0.006). Side effects 35% with combination vs ~18% with NTG alone PMID 1505148 (NAC potentiates NTG headache/arterial response); PMID 3137075 (unstable angina hypotension data); StatPearls NBK537183 | HIGH | Empty stomach, separate from nitroglycerin 4+ hours | Monitor blood pressure |
| Iron Verify → | Thyroid medication, antibiotics (tetracyclines, quinolones), antacids, levodopa | Chelation reduces absorption of both iron and the co-administered drug. Levothyroxine absorption reduced if taken within 4 hours. Only 31.8% of patients are told to separate; only 40.7% of those comply PMC8002057 (levothyroxine-supplement systematic review); NIH ODS iron fact sheet; Drugs.com iron interaction checker | HIGH | Empty stomach with vitamin C, separate from thyroid 4 hours, antibiotics 2-4 hours | Retest ferritin at 3 months |
| Magnesium Verify → | Fluoroquinolones, tetracyclines, bisphosphonates, levothyroxine | Chelation reduces antibiotic and thyroid medication absorption. Same 4-hour separation rule as iron and calcium PMC8002057 (levothyroxine interaction systematic review); Drugs.com magnesium interaction checker | MODERATE | Separate from antibiotics 2+ hours, thyroid medication 4+ hours | Watch for loose stools >400mg |
| Omega-3 (high dose) Verify → | Blood thinners, pre-surgery | Additive anticoagulant at >3g/day. EPA component has antiplatelet properties. Risk is dose-dependent - standard 1-2g doses have minimal bleeding risk PMC9586694 (dietary supplements and bleeding review); Drugs.com omega-3 interaction checker | MODERATE | With fat-containing meal | Watch for easy bruising at high doses. At therapeutic doses (>3g), discuss with prescriber if on anticoagulants |
| Vitamin D Verify → | Thiazide diuretics, digoxin | Thiazides reduce calcium excretion while vitamin D increases calcium absorption - combined hypercalcemia risk. Hypercalcemia potentiates digoxin toxicity (arrhythmia risk) Drugs.com vitamin D interaction checker; Mayo Clinic vitamin D guidance | MODERATE | With fat, morning preferred | Monitor serum calcium, especially on thiazides or digoxin |
| Alpha Lipoic Acid Verify → | Diabetes medications (insulin, metformin, sulfonylureas) | Additive blood sugar lowering - hypoglycemia risk. 29 known drug interactions on Drugs.com (all minor). Relatively clean interaction profile compared to other supplements Drugs.com 29 interactions listed; Examine.com ALA research page | MODERATE | Empty stomach, 30 min before meals | Monitor blood glucose more frequently when starting ALA on diabetes medications |
| Ashwagandha Verify → | Thyroid medications, immunosuppressants, sedatives | Animal studies: increased T4 by ~40%. Case reports of thyroid level changes in humans (2024). May stimulate immune function - opposes immunosuppressants. Additive sedation with CNS depressants NCCIH ashwagandha safety review (2024); GoodRx 5 ashwagandha interactions; Examine.com ashwagandha research | MODERATE | With food, start low 300mg | Recheck thyroid labs 6 weeks after starting. Monitor immune markers if on immunosuppressants |
| Methylene Blue Verify → | SSRIs, SNRIs, MAOIs, Tramadol, Buspirone, clomipramine | Potent reversible MAO-A inhibitor at nanomolar concentrations. At least 14 published case reports of serotonin toxicity, 1 fatal. FDA safety communication issued October 2011 PMC2078225 (Gillman & Ramsay 2006 - first MAO-A inhibition demonstration); FDA Drug Safety Communication October 2011; PMC11089602 | AVOID | Only pharmaceutical-grade USP, off serotonergic meds 2+ weeks | Watch for agitation, hyperthermia, clonus, hyperreflexia |
| Berberine Verify → | Metformin, insulin, other diabetes medications | Additive blood sugar lowering - hypoglycemia risk. Berberine may increase metformin levels when taken 2 hours before GoodRx clinical review; PMID 35489323 | HIGH | With meals. If on metformin, take at the same time (not 2 hours before) | Monitor blood glucose more frequently. Watch for dizziness, sweating, confusion |
| Curcumin / Turmeric Verify → | Warfarin, clopidogrel, aspirin, anticoagulants | Antiplatelet effect increases bleeding risk. Case report: INR rose above 10 in a patient on warfarin after starting turmeric PMID 22531131; Medsafe NZ alert 2018 | HIGH | With fat for absorption. Stop 2 weeks before surgery | Monitor INR if on warfarin. Watch for unusual bruising or bleeding |
| CoQ10 Verify → | Warfarin, blood pressure medications | May reduce warfarin effectiveness (structurally similar to vitamin K). May enhance blood pressure medication effects PMID 17482884; AHA/ACC guidance | MODERATE | With fat-containing meal | Monitor INR if on warfarin. Monitor blood pressure if on antihypertensives |
| Creatine Verify → | NSAIDs (long-term), diuretics, nephrotoxic drugs | Theoretical kidney stress with nephrotoxic drugs. Dehydration risk with diuretics. May cause false-positive on kidney function tests (elevated creatinine) Drugs.com interaction checker; DrugBank DB00148 | LOW | 5g daily with any meal. Stay well-hydrated | Tell your doctor you take creatine before any kidney function test - it raises creatinine without kidney damage |
| Melatonin Verify → | Blood pressure medications, immunosuppressants, sedatives, anticoagulants | Enhances blood pressure lowering (hypotension risk). Stimulates immune function - may counteract immunosuppressants. Additive sedation with CNS depressants Mayo Clinic drug interactions; GoodRx 9 interactions guide | MODERATE | 30-60 min before bed. Low dose (0.3-1mg) first | Monitor blood pressure if on antihypertensives. Avoid if on immunosuppressants post-transplant |
| Lion's Mane Verify → | Anticoagulants, antiplatelet drugs | Inhibits collagen-induced platelet aggregation - slows blood clotting. Additive bleeding risk with blood thinners WebMD lion's mane interactions; in vitro platelet studies | MODERATE | With food. Stop 2 weeks before surgery | Watch for unusual bruising, nosebleeds, slow wound healing |
| Quercetin Verify → | Cyclosporine, antibiotics (fluoroquinolones), CYP3A4-metabolized drugs | Alters cyclosporine levels (both increases and decreases reported). Inhibits CYP3A4 and P-glycoprotein - may increase levels of many drugs PMID 21466223; PMC5042751 | HIGH | On empty stomach. Separate from antibiotics 2+ hours | Avoid if on cyclosporine or other transplant drugs. Monitor drug levels if on narrow-therapeutic-index medications |
| Probiotics Verify → | Immunosuppressants (cyclosporine, tacrolimus, azathioprine), chemotherapy | Risk of bacteremia or fungemia in immunocompromised patients. Live organisms can cross gut barrier when immune system is suppressed PMID 26287986; Frontiers in Neuroscience review | HIGH | With or after meals. Separate from antibiotics 2+ hours | Avoid live cultures if immunosuppressed. Discuss with transplant team before starting |
| Zinc Verify → | Fluoroquinolones, tetracyclines, penicillamine, bisphosphonates | Chelation reduces absorption of both zinc and the antibiotic. Reduces penicillamine absorption NIH ODS zinc fact sheet; Drugs.com interaction checker | MODERATE | Take 2 hours before or 4-6 hours after antibiotics. Separate from penicillamine 1+ hour | Do not exceed 40mg/day long-term without medical supervision (copper depletion risk) |
| Selenium Verify → | Cisplatin, barbiturates, blood thinners | May reduce cisplatin effectiveness. Additive sedation with barbiturates. Mild anticoagulant effect at high doses NIH ODS selenium fact sheet; WebMD selenium interactions | LOW | With food. Do not exceed 400mcg/day | Monitor for garlic breath, hair loss, or nail changes (toxicity signs) |
| Bacopa Monnieri Verify → | Thyroid medications, amitriptyline, CYP1A2/2C9/2C19/3A4-metabolized drugs | Inhibits CYP1A2, 2C9, 2C19, 3A4. Increases amitriptyline levels in animal studies. May increase thyroid hormone levels (T4 by ~40% in animal models) PMC6271976; SciELO Brazil amitriptyline study; Examine.com bacopa FAQ | HIGH | With food. Separate from thyroid medication 4+ hours | Recheck thyroid labs if starting bacopa. Monitor for drug level changes if on CYP-metabolized medications |
| Rhodiola Rosea Verify → | MAOIs, SSRIs, SNRIs, antihypertensives, CYP2C9/3A4-metabolized drugs | MAO inhibitory activity - serotonin syndrome risk with serotonergic drugs. Potent CYP3A4, CYP2D6, and P-gp inhibition. Additive blood pressure lowering PMID 25413939 (case report); PMC9881059; MSKCC rhodiola monograph | HIGH | Morning with food (stimulating). Avoid evening dosing | Do not combine with antidepressants without medical supervision. Monitor blood pressure |
| Alpha-GPC Verify → | Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine), scopolamine | Excessive acetylcholine accumulation with AChE inhibitors - GI upset, bradycardia, urinary issues. Opposes scopolamine effects PMID 1662399; ADDF cognitive vitality review | MODERATE | With food. Morning or early afternoon (mildly stimulating) | Watch for GI symptoms, slow heart rate, or excessive salivation if combining with AChE inhibitors |
| Phosphatidylserine Verify → | Anticoagulants (warfarin, heparin), antiplatelet drugs | Enhances heparin anticoagulant effect. Mild anticoagulant properties may increase bleeding risk with blood thinners PMID 7314577; Cleveland Clinic PS monograph; RxList | MODERATE | With food. Separate from blood thinners | Monitor INR if on warfarin. Watch for unusual bruising |
| L-Theanine Verify → | Blood pressure medications, sedatives, benzodiazepines | Additive blood pressure lowering with antihypertensives. Mild additive sedation with CNS depressants WebMD theanine interactions; PMC3518171 | LOW | Any time. 200mg typical dose | Monitor blood pressure if on antihypertensives. Low overall risk - one of the safest supplements |
| Methylfolate (5-MTHF) Verify → | Methotrexate, phenytoin, carbamazepine, valproic acid | May reduce methotrexate effectiveness. Anticonvulsants interfere with folate metabolism - may need higher doses. 25 known drug interactions (3 major) Drugs.com 25 interactions; DrugBank DB04789 | MODERATE | With food. Morning preferred | If on methotrexate, do not supplement without oncologist approval. Monitor anticonvulsant levels |
| Vitamin B12 Verify → | Metformin, PPIs (omeprazole), colchicine, chloramphenicol | Not a dangerous interaction - these drugs DEPLETE B12. Metformin impairs B12 absorption. PPIs reduce gastric acid needed for B12 release. Combined metformin + PPI significantly increases deficiency risk PMC3507616; MHRA 2024 guidance; PMID Jung 2025 | LOW | Sublingual methylcobalamin bypasses absorption issues. Any time of day | Test B12 levels annually if on metformin or PPIs. MHRA 2024 guidance: monitor all metformin patients |
| Vitamin C (high dose) Verify → | Warfarin, estrogen/HRT, chemotherapy, aluminum-containing antacids | High doses may reduce warfarin effectiveness. Increases estrogen levels (HRT side effects). May interfere with chemotherapy. Increases aluminum absorption with antacids PMC11082382; Mayo Clinic vitamin C; GoodRx interactions | MODERATE | With food. Standard doses (500-1000mg) are generally safe. Risks mainly at >2g/day | Monitor INR if on warfarin. Avoid high doses during chemotherapy without oncologist approval |
| Electrolytes / Sodium Loading Verify → | Lithium, ACE inhibitors, potassium-sparing diuretics | Sodium changes alter lithium clearance - toxicity risk. Potassium supplements + ACE inhibitors + spironolactone = dangerous hyperkalemia (K+ rose 1.2 mmol/L in studies). Sodium loading counters diuretic effects PMID 8521679; PMC4955086; PMC7358048 | HIGH | Spread throughout day. Monitor if on any cardiac or psychiatric medications | Lithium levels must be checked when changing sodium intake. Monitor potassium if on ACE inhibitors or spironolactone |
| Acetyl-L-Carnitine (ALCAR) Verify → | Warfarin, acenocoumarol, thyroid medications, anticonvulsants | Increases anticoagulant effect of warfarin/acenocoumarol. May decrease thyroid hormone effectiveness. May lower seizure threshold in people with seizure history WebMD ALCAR interactions; RxList ALCAR precautions; DrugBank DB08842 | MODERATE | With food. Separate from thyroid medication 4h | Monitor INR if on warfarin. Do not use if seizure history without medical guidance |
| Saffron Verify → | SSRIs/SNRIs (serotonin risk above 100mg/day), anticoagulants, antihypertensives | At 30mg/day: clinical trials show safe with SSRIs. Above 100mg/day: increased serotonergic load. Anticoagulant properties - case report of bleeding with rivaroxaban. Additive blood pressure lowering PMC11426294 (saffron in depression comparative review); WebMD saffron interactions; rivaroxaban case report | MODERATE | With food. Standard dose 30mg/day standardized extract | Keep at 30mg/day or below when on SSRIs. Watch for bleeding signs if on anticoagulants. Monitor BP if on antihypertensives |
| SAMe (S-adenosylmethionine) Verify → | SSRIs, SNRIs, MAOIs, clomipramine, tramadol, meperidine, levodopa | Increases serotonin levels - serotonin syndrome risk with serotonergic drugs. Methylates levodopa, reducing its effectiveness in Parkinson's disease. AVOID with MAOIs Mayo Clinic SAMe guidance; NCCIH SAMe monograph; PMID 20595412 (SAMe + SSRI RCT); Merck Manual SAMe | HIGH | Empty stomach. Morning preferred (mildly activating) | Do not combine with antidepressants without physician supervision. Watch for serotonin syndrome symptoms. Monitor Parkinson's symptoms if on levodopa |
| Tongkat Ali Verify → | Diabetes medications (insulin, metformin, sulfonylureas), hormone-sensitive cancer treatments | May lower blood sugar - hypoglycemia risk with diabetes meds. CYP450 enzyme interactions possible. Increases testosterone - contraindicated in hormone-sensitive cancers (prostate, breast) RxList tongkat ali interactions; NCBI LiverTox NBK609015; WebMD tongkat ali | MODERATE | With food. Morning preferred | Monitor blood glucose if diabetic. Contraindicated in hormone-sensitive cancers. Stop before testosterone blood tests |
| Milk Thistle (Silymarin) Verify → | Warfarin, methadone, statins (atorvastatin), chemotherapy agents | In vitro CYP2C9 and CYP3A4 inhibition, but clinical studies show minimal effect at standard doses. Sensitive drugs (warfarin, opioids, anti-arrhythmics) still warrant caution. Chemotherapy interactions require oncologist supervision PMC4164972 (CYP450 clinical study - no significant effect); Pharmacy Times milk thistle interactions; Mayo Clinic milk thistle | LOW | With food. Typically 200-400mg standardized extract | Generally safe at standard doses. Consult oncologist if on chemotherapy. Monitor INR if on warfarin |
| Myo-Inositol Verify → | Lithium, diabetes medications (may have additive glucose-lowering effect) | Lithium may interfere with inositol signaling (lithium depletes inositol - this is part of its mechanism). Metformin and myo-inositol may have additive insulin-sensitizing effects - monitor blood glucose PMC5655679 (myo-inositol PCOS meta-analysis); MDPI comparative study with metformin | LOW | With food or empty stomach. Typical dose 2-4g/day for PCOS | If on lithium, discuss with psychiatrist. If on metformin, monitor blood glucose |
| Oregano Oil (Carvacrol) Verify → | Anticoagulants, iron/zinc/copper supplements, diabetes medications | Anticoagulant activity from carvacrol/thymol - increased bleeding risk. Reduces absorption of iron, zinc, copper (take 2h apart). May lower blood sugar (hypoglycemia risk with diabetes meds). Case report of hemorrhagic risk (2025) PMID 39793412 (2025 hemorrhagic risk case report); WebMD oregano interactions; StyleCraze oregano oil side effects | MODERATE | With food. Separate from mineral supplements 2h. Stop 2 weeks before surgery | Watch for unusual bleeding. Monitor blood sugar if diabetic. Short courses (2-4 weeks) preferred |
| Vitamin E Verify → | Warfarin, anticoagulants, antiplatelet drugs, chemotherapy | Inhibits vitamin K-dependent clotting factors and platelet aggregation. Risk mainly at >400 IU/day. Standard multivitamin doses (15-30mg) are safe. May interfere with some chemotherapy mechanisms PMID 8629604 (vitamin E + warfarin); PMC3886776 (vitamin E serum levels and bleeding); Cambridge nutrition reviews molecular basis | MODERATE | With fat-containing food. Standard dose 15mg (22 IU) daily | Monitor INR if on warfarin. Avoid high-dose (>400 IU) without medical supervision. Stop 2 weeks before surgery |
| Vitamin K2 (MK-7) Verify → | Warfarin, other vitamin K antagonist anticoagulants | Directly opposes warfarin. Doses as low as 10mcg MK-7 significantly influenced anticoagulation in some individuals. Dose-dependent antagonism of warfarin. DOACs (apixaban, rivaroxaban) are NOT affected because they block different clotting pathways PMID 23530987 (MK-7 dose-response in anticoagulation); PMC4972987 (K2 and warfarin perioperative); Blood ASH vitamin K supplementation caution | AVOID | With fat. If on warfarin, do NOT take K2 supplements. If on DOACs, discuss with doctor (likely safe) | If on warfarin: AVOID K2 supplements entirely. Monitor INR if any vitamin K source changes |
| Biotin (Vitamin B7) Verify → | No direct drug interactions - but causes DANGEROUS lab test interference | FDA warning: high-dose biotin (5000-10000mcg) falsifies thyroid tests, troponin, hormones, and other biotin-streptavidin-based assays. Can mimic Graves disease on labs. One death reported from missed heart attack due to falsely low troponin PMC5951654 (biotin lab interference); PMC6663274 (thyroid bioassay case series); PMC6802814 (FDA warning case report); AACC guidance document | HIGH | Any time. Stop 48-72h before ANY blood work | ALWAYS tell your lab/doctor you take biotin. Stop 48-72h before blood tests. TRAb can take 7 days to normalize after stopping |
| Choline / Phosphatidylcholine Verify → | Acetylcholinesterase inhibitors (donepezil, rivastigmine), atropine | May increase acetylcholine levels - additive effect with AChE inhibitors. Gut bacteria convert choline to TMA/TMAO (associated with cardiovascular risk at high supplemental doses). Opposes atropine effects NIH ODS choline fact sheet; HelloPharmacist choline interactions; PMC8410632 (choline supplements raise TMAO) | LOW | With food. Dietary choline from eggs is preferred over supplements when possible | If on AChE inhibitors, monitor for GI symptoms and bradycardia. TMAO concern mainly at supplemental doses, not dietary |
| Iodine Verify → | Thyroid medications (levothyroxine, methimazole), lithium, amiodarone | Excess iodine can cause hyper- OR hypothyroidism depending on underlying thyroid status. Lithium + iodine = additive hypothyroid effect. Amiodarone already contains 37.5% iodine by weight - supplemental iodine is dangerous. Jod-Basedow disease risk in multinodular goiter PMC1070767 (medications affecting thyroid); PMC3028253 (iodine-induced hyperthyroidism); WebMD iodine interactions; Drugs.com iodine + levothyroxine | HIGH | With food. Do not exceed 150-300mcg/day without medical supervision | Test thyroid function before supplementing. NEVER supplement iodine if on amiodarone. Check TSH 6-8 weeks after starting |
| Riboflavin (Vitamin B2) Verify → | Doxorubicin (chemotherapy), anticholinergic drugs, tetracycline | Minimal drug interactions at standard doses. May affect doxorubicin effectiveness. Anticholinergic drugs may reduce riboflavin absorption. Generally one of the safest supplements Drugs.com riboflavin interactions; NIH ODS riboflavin fact sheet | LOW | With food. Typical migraine prevention dose: 400mg/day | Yellow-orange discoloration of urine is normal. Safe even at high doses |
| Thiamine (Vitamin B1) Verify → | No significant drug interactions at supplemental doses | Extremely safe. No known clinically significant drug interactions. Water-soluble - excess is excreted. High-dose IV thiamine can rarely cause anaphylaxis but oral is safe Drugs.com thiamine interactions (no significant interactions listed); NIH ODS thiamine fact sheet | LOW | With food. Any time of day | No monitoring needed. One of the safest supplements available |
| Calcium Verify → | Levothyroxine, antibiotics (tetracyclines, quinolones), bisphosphonates, iron | Chelation reduces absorption of thyroid medication, antibiotics, bisphosphonates, and iron. Separate all by 2-4 hours. Thiazide diuretics + calcium + vitamin D = hypercalcemia risk PMC8002057 (levothyroxine interaction review); Drugs.com calcium interactions | HIGH | With food (citrate form) or without (carbonate form needs stomach acid). Separate from other meds 2-4h | Follow 4-hour separation rule for levothyroxine, 2-hour for antibiotics. Monitor calcium levels if on thiazides |
| Boron Verify → | Estrogen, hormone replacement therapy | May increase estrogen levels. Generally safe at doses under 20mg/day. Limited drug interaction data WebMD boron interactions; NIH ODS boron fact sheet | LOW | With food | Avoid high doses if on HRT or estrogen-sensitive conditions. Stay under 20mg/day |
| Chromium Verify → | Diabetes medications (insulin, metformin, sulfonylureas), levothyroxine | Additive blood sugar lowering with diabetes meds - hypoglycemia risk. May reduce levothyroxine absorption (take 4h apart). Generally well-tolerated at doses under 1000mcg/day WebMD chromium interactions; Drugs.com chromium picolinate interactions | MODERATE | With food. Separate from levothyroxine 4h | Monitor blood glucose if on diabetes medications. Separate from thyroid medication |
| D-Ribose Verify → | Diabetes medications (insulin, oral hypoglycemics) | May lower blood sugar - additive hypoglycemia risk with diabetes medications. Limited interaction data WebMD D-ribose interactions; RxList D-ribose precautions | LOW | With meals to reduce GI upset. Typical dose 5g 3x/day | Monitor blood glucose if diabetic. Start low dose |
| DAO Enzyme Verify → | No significant drug interactions known | Breaks down dietary histamine in the gut. Does not enter systemic circulation. No known CYP interactions. One of the safest supplements for medication co-administration PMID 31807350 (DAO supplementation trial); Drugs.com DAO interactions | LOW | 15 minutes before meals containing histamine | No monitoring needed. Safe with all medications |
| Digestive Enzymes Verify → | Blood thinners (bromelain component), acarbose | Bromelain (in some enzyme blends) has mild antiplatelet activity. May reduce effectiveness of acarbose (alpha-glucosidase inhibitor). Otherwise very safe WebMD digestive enzymes interactions; Drugs.com bromelain interactions | LOW | With meals | If blend contains bromelain, watch for bruising on anticoagulants |
| Glycine Verify → | Clozapine (antipsychotic) | Extremely safe amino acid. Only known interaction: may affect clozapine levels. No CYP interactions. Used as a sleep aid at 3g before bed WebMD glycine interactions; Drugs.com glycine interactions | LOW | Before bed for sleep (3g). Any time for other uses | If on clozapine, discuss with psychiatrist. Otherwise no monitoring needed |
| Apigenin (Chamomile) Verify → | CYP1A2 substrates (caffeine, clozapine), CYP3A4 substrates, sedatives | In vitro CYP1A2 and CYP3A4 inhibition. Additive sedation with CNS depressants. Clinical significance at supplement doses is unclear WebMD chamomile interactions; Examine.com apigenin research | LOW | Evening preferred (sedating). With food | Monitor sedation if combining with sleep medications. Generally safe as chamomile tea |
| Glutathione (Liposomal) Verify → | Chemotherapy (may reduce effectiveness), nitroglycerin (potentiates vasodilation similar to NAC) | As the body's master antioxidant, may theoretically reduce oxidative-stress-dependent chemotherapy effectiveness. Potentiates nitroglycerin like NAC. Otherwise very safe with minimal drug interactions Drugs.com glutathione interactions; clinical pharmacology references | LOW | Empty stomach preferred for absorption. Morning or before bed | Consult oncologist if on chemotherapy. Avoid with nitroglycerin |
| Ginger (Prokinetic) Verify → | Anticoagulants (warfarin, aspirin), diabetes medications | Mild antiplatelet activity - additive bleeding risk with blood thinners at high doses. May lower blood sugar. Standard culinary doses are safe; supplement doses (500-1000mg) warrant more caution WebMD ginger interactions; Drugs.com ginger interactions | LOW | With meals or between meals. 500-1000mg extract for prokinetic use | Watch for bruising if on anticoagulants. Monitor blood sugar if diabetic. Culinary amounts are safe |
| Lavender Oil (Silexan) Verify → | Sedatives, CNS depressants, CYP3A4-metabolized drugs | Additive sedation with benzodiazepines, Z-drugs, alcohol. Silexan (standardized lavender oil) has anxiolytic effects comparable to low-dose lorazepam. Potential CYP3A4 interaction Drugs.com lavender interactions; Gaiaherbs lavender safety; Examine.com lavender research | LOW | With food. Typical dose 80-160mg Silexan daily | Monitor for excessive sedation when combining with other sedatives. Generally well-tolerated |
| Luteolin Verify → | CYP3A4-metabolized drugs (theoretical), anticoagulants | In vitro CYP inhibition but limited clinical data on drug interactions. Mild antiplatelet properties. Primarily studied for mast cell stabilization in MCAS PMID 26190965 (Theoharides mast cell/neuroscience); WebMD luteolin interactions | LOW | With food. 100-200mg daily | Limited drug interaction data. Exercise caution if on narrow-therapeutic-index medications |
| PEA (Palmitoylethanolamide) Verify → | No significant drug interactions known | Endogenous fatty acid amide - the body already produces PEA. No known CYP interactions. No serotonergic activity. One of the cleanest supplement interaction profiles available PMID 27220803 (PEA review); Drugs.com PEA interactions | LOW | With or without food. 600mg 2-3x daily for pain | No monitoring needed. Safe with essentially all medications |
| Sulforaphane (Broccoli Sprout Extract) Verify → | CYP1A2 substrates (caffeine, theophylline), thyroid medications (goitrogenic at extreme doses) | Induces Phase 2 detoxification enzymes (NRF2 pathway). May affect CYP1A2 metabolism. Cruciferous compounds are mildly goitrogenic in iodine-deficient individuals - not clinically significant at supplement doses Examine.com sulforaphane research; WebMD broccoli sprout interactions | LOW | With food. Typical dose 30-60mg sulforaphane equivalent | Safe at standard doses. Not a concern for thyroid at normal supplement levels unless severely iodine-deficient |
| Chlorella Verify → | Warfarin (contains vitamin K), immunosuppressants | Contains vitamin K - may reduce warfarin effectiveness. May stimulate immune function - opposes immunosuppressants. Heavy metal binding properties (used as detox binder) WebMD chlorella interactions; Drugs.com chlorella interactions | MODERATE | With food. Separate from medications 2h (binding properties) | Monitor INR if on warfarin. Avoid if on immunosuppressants. Separate from medications due to binding |
| Spearmint Tea Verify → | Iron supplements (tanins reduce absorption), diabetes medications | Anti-androgenic properties (used therapeutically in PCOS for hirsutism). Tannins reduce iron absorption. May have mild blood sugar lowering effect. Very safe overall WebMD spearmint interactions; PCOS spearmint tea studies | LOW | Between meals (not with iron-rich foods or iron supplements) | Separate from iron supplements by 1-2 hours. Monitor if on anti-androgen therapy |
| L-Glutamine Verify → | Lactulose (hepatic encephalopathy), anticonvulsants | Converted to glutamate in the body - may theoretically worsen hepatic encephalopathy (opposes lactulose mechanism). May affect anticonvulsant threshold via glutamate. Otherwise very safe amino acid WebMD L-glutamine interactions; Drugs.com L-glutamine interactions | LOW | Empty stomach. 5g/day typical dose for gut repair | Avoid in liver failure or hepatic encephalopathy. Safe for most other people |
| L-Lysine Verify → | Calcium supplements (increases calcium absorption), aminoglycoside antibiotics | Increases calcium absorption - monitor if already taking high-dose calcium. May increase aminoglycoside toxicity (rare). Otherwise very safe amino acid with minimal interactions WebMD lysine interactions; Drugs.com L-lysine interactions | LOW | Empty stomach preferred. 1-3g/day for viral suppression | Monitor calcium levels if taking both. Otherwise no monitoring needed |
| L-Arginine Verify → | Blood pressure medications, nitrates (nitroglycerin, sildenafil), anticoagulants | Vasodilator - additive blood pressure lowering with antihypertensives. Potentiates nitrate effects (dangerous hypotension with nitroglycerin or sildenafil). Mild antiplatelet activity WebMD L-arginine interactions; Mayo Clinic L-arginine guidance; Drugs.com L-arginine interactions | MODERATE | Between meals. Start at low dose | Monitor blood pressure if on antihypertensives. AVOID with nitrates. Watch for hypotension symptoms |
| Stinging Nettle Verify → | Blood pressure medications, diabetes medications, anticoagulants, lithium, sedatives | May lower blood pressure and blood sugar. Diuretic effect may affect lithium levels. Mild anticoagulant properties. Additive sedation WebMD stinging nettle interactions; PMID 2189951 (Mittman 1990 allergic rhinitis RCT) | MODERATE | With food. Typical dose 300-600mg extract daily | Monitor blood pressure, blood sugar, and lithium levels if applicable |
| B-Complex Verify → | See individual B vitamins (B1, B2, B6, B12, folate). Biotin component causes lab interference. B6 >100mg/day long-term can cause neuropathy | Standard B-complex doses are very safe. High-dose biotin component can falsify lab tests. High-dose B6 (>100mg/day for months) causes peripheral neuropathy. Methylated forms bypass MTHFR variants PMC5951654 (biotin lab interference); NIH ODS B-vitamin fact sheets | LOW | With food. Morning preferred (B vitamins are mildly energizing) | Stop 48h before blood tests (biotin interference). Do not exceed B6 >100mg/day long-term |
| MCT Oil / Caprylic Acid Verify → | No significant drug interactions | GI upset (diarrhea, cramping) is the main side effect, especially when starting. No known CYP interactions. Safe with essentially all medications. Start low (1 tsp) and increase gradually WebMD MCT oil interactions; Drugs.com MCT oil interactions | LOW | With food. Start with 1 tsp, increase to 1-2 tbsp over 1-2 weeks | No drug interaction monitoring needed. Watch for GI tolerance |
| Japanese Knotweed (Resveratrol) Verify → | Anticoagulants, CYP3A4/CYP1A2-metabolized drugs, estrogen | Resveratrol has antiplatelet properties - additive bleeding risk. Inhibits CYP3A4 and CYP1A2 in vitro. Phytoestrogenic - may affect hormone-sensitive conditions. Herxheimer reactions possible at antimicrobial doses (Lyme protocol) PMID 32154254 (Johns Hopkins anti-borrelial study); WebMD resveratrol interactions | MODERATE | With food. Start very low for Lyme protocol (Herxheimer risk). Standard resveratrol: 100-500mg daily | Watch for bleeding signs if on anticoagulants. Start extremely low if using for Lyme (Buhner protocol). Monitor estrogen-sensitive conditions |
| Cat's Claw (Uncaria tomentosa) Verify → | Anticoagulants, antihypertensives, immunosuppressants, CYP3A4-metabolized drugs | Antiplatelet activity. Lowers blood pressure. Immunostimulant - opposes immunosuppressants. CYP3A4 inhibition. Interacts with anticoagulants and antihypertensives PMID 15649507 (anti-borrelial); PMID 32154254 (Johns Hopkins); WebMD cat's claw interactions | MODERATE | With food. Start low (Herxheimer risk in Lyme). Typical dose 500mg 3x/day | Watch for bleeding, low blood pressure. Avoid if on immunosuppressants. Stop 2 weeks before surgery |
| Mycotoxin Binders (Charcoal, Bentonite Clay, Cholestyramine) Verify → | ALL oral medications (binders reduce absorption of everything) | Non-selective binding - activated charcoal and clay bind medications, supplements, and nutrients indiscriminately. MUST separate from all other oral medications by 2-4 hours. Cholestyramine is prescription and has specific interaction warnings Drugs.com activated charcoal interactions; FDA cholestyramine label; Clinical toxicology references | HIGH | ALWAYS separate from all medications and supplements by at least 2 hours (4 hours preferred). Take on empty stomach between meals | Time all medications carefully. If on narrow-therapeutic-index drugs (warfarin, levothyroxine, lithium), 4-hour separation is mandatory |
| PHGG (Partially Hydrolyzed Guar Gum) Verify → | No significant drug interactions known | Soluble prebiotic fiber. May slightly slow absorption of co-administered medications. Does not bind medications like charcoal. Very safe with all drugs PMID 21050236 (Furnari rifaximin + PHGG trial); Drugs.com guar gum interactions | LOW | With water. Can mix into food/drinks. 5g daily for SIBO | No monitoring needed. May cause mild gas when starting - increase dose gradually |
| Herbal Antimicrobials (Berberine + Oregano Oil combination) Verify → | See individual entries for Berberine and Oregano Oil. Combined: additive blood sugar lowering, anticoagulant effects, and CYP interactions | The combination amplifies individual risks. Berberine CYP3A4/2D6 interactions + oregano oil anticoagulant/mineral chelation. Monitor more closely than with either alone PMID 14894990 (Chedid herbal vs rifaximin SIBO trial); Combined risk profile from individual entries | HIGH | With meals. Typical SIBO course: 4-6 weeks. Separate from minerals 2h | Monitor blood sugar, bleeding signs, and GI tolerance. Short courses preferred. See berberine and oregano oil individual entries |
| Peppermint Oil (Enteric-Coated) Verify → | Cyclosporine (CYP3A4 inhibition), antacids/PPIs (dissolve enteric coating prematurely), iron supplements | CYP3A4 inhibition may increase cyclosporine levels. Antacids/PPIs dissolve enteric coating, causing heartburn and reduced gut-level delivery. May reduce iron absorption. Enteric coating is essential - non-coated causes GERD WebMD peppermint oil interactions; Drugs.com peppermint interactions | LOW | 30-60 min before meals (empty stomach for enteric-coated). Do NOT take with antacids | If on cyclosporine, monitor drug levels. Ensure enteric-coated form. Separate from iron 2h |
| Chinese Skullcap (Scutellaria baicalensis) Verify → | CYP1A2/CYP2C19 substrates, statins, hepatotoxic drugs, sedatives | Wogonin component inhibits CYP1A2 and CYP2C19. Decreased statin levels in healthy volunteers. Case reports of acute liver injury (hepatotoxicity). Limited safety data - mostly used in Bartonella protocols (Buhner) PMID 33711551 (drug-herb interaction review); PMID 30957370 (liver injury case report); MSKCC scutellaria monograph | MODERATE | With food. Short courses preferred. Monitor liver function | Check liver enzymes if using >2 weeks. Watch for jaundice, dark urine, abdominal pain. Avoid if liver disease |
| Cryptolepis (Cryptolepis sanguinolenta) Verify → | Limited data - caution with CYP-metabolized drugs, antidiabetic medications, antimalarials | Very limited published interaction data. Traditional antimalarial - may interact with antimalarial drugs. Contains cryptolepine which has blood sugar lowering effects. Primarily studied for antimicrobial activity against Borrelia and Babesia. NO well-characterized drug interaction profile Limited published data. Used in Buhner/Zhang Bartonella protocols. No Drugs.com or Examine.com entry exists. Exercise caution | MODERATE | With food. Used in Bartonella/Babesia protocols under practitioner supervision only | No established monitoring guidelines. Use under practitioner supervision only. Monitor blood sugar if diabetic. Report any unusual symptoms |
| Butyrate (Sodium/Calcium Butyrate) Verify → | May attenuate CYP induction by other drugs (phenobarbital studied). No major known drug interactions | Short-chain fatty acid normally produced by gut bacteria. Supplemental form generally well-tolerated. Animal research shows butyrate may attenuate CYP2H and CYP3A induction - could theoretically affect drug metabolism but clinical significance is unclear. Crosses blood-brain barrier. HDAC inhibitor properties PMC4903954 (butyrate neuroepigenetics); PMC10359501 (SCFAs gut-brain review); PMID 26614344 (butyrate CYP interaction animal study) | LOW | With food. Typical dose 300-600mg 2-3x/day. Enteric-coated or tributyrin forms for gut delivery | Generally safe. Start low (GI adjustment period). No established drug interaction monitoring needed |
Do NOT combine with:
SSRIs, SNRIs, MAOIs, Tramadol, Triptans
Serotonin syndrome - potentially fatal. Case report: serotonin syndrome from sertraline + 5-HTP supplement led to rhabdomyolysis and acute compartment syndrome
PMC5580516 (case report: SSRI + 5-HTP → serotonin syndrome → rhabdomyolysis); PMC6184959 (serotonin toxicity review)
Do NOT combine with:
SSRIs, birth control, blood thinners, cyclosporine
Potent CYP3A4 inducer (degree correlates with hyperforin content). Reduces drug levels of cyclosporine, birth control, anticoagulants. Also causes serotonin syndrome with SSRIs - sertraline and paroxetine most commonly reported
PMC1874438 (clinical outcomes review); PMC2782080 (updated clinical observations); PMID 15260917 (pharmacokinetic interactions); PMC12420457 (SSRI interactions)
Do NOT combine with:
Blood thinners, NSAIDs
Increased bleeding risk. 2025 meta-analysis: OR 1.08 (p<0.001) for bleeding when combined with antiplatelets. Clopidogrel and aspirin showed highest interaction prevalence. However, controlled RCTs show less clear risk than case reports suggest
PMID 40198642 (2025 comprehensive analysis, n=1985); PMID 21923430 (systematic review/meta-analysis); PMID 18214851 (antiplatelet interaction review)
Do NOT combine with:
Nitroglycerin, activated charcoal
Forms S-nitroso-NAC with nitroglycerin - potentiates vasodilation and headache. Study: headache score tripled (3 vs 1), symptomatic hypotension in 7 vs 0 patients (p=0.006). Side effects 35% with combination vs ~18% with NTG alone
PMID 1505148 (NAC potentiates NTG headache/arterial response); PMID 3137075 (unstable angina hypotension data); StatPearls NBK537183
Do NOT combine with:
Thyroid medication, antibiotics (tetracyclines, quinolones), antacids, levodopa
Chelation reduces absorption of both iron and the co-administered drug. Levothyroxine absorption reduced if taken within 4 hours. Only 31.8% of patients are told to separate; only 40.7% of those comply
PMC8002057 (levothyroxine-supplement systematic review); NIH ODS iron fact sheet; Drugs.com iron interaction checker
Do NOT combine with:
Fluoroquinolones, tetracyclines, bisphosphonates, levothyroxine
Chelation reduces antibiotic and thyroid medication absorption. Same 4-hour separation rule as iron and calcium
PMC8002057 (levothyroxine interaction systematic review); Drugs.com magnesium interaction checker
Do NOT combine with:
Blood thinners, pre-surgery
Additive anticoagulant at >3g/day. EPA component has antiplatelet properties. Risk is dose-dependent - standard 1-2g doses have minimal bleeding risk
PMC9586694 (dietary supplements and bleeding review); Drugs.com omega-3 interaction checker
Do NOT combine with:
Thiazide diuretics, digoxin
Thiazides reduce calcium excretion while vitamin D increases calcium absorption - combined hypercalcemia risk. Hypercalcemia potentiates digoxin toxicity (arrhythmia risk)
Drugs.com vitamin D interaction checker; Mayo Clinic vitamin D guidance
Do NOT combine with:
Diabetes medications (insulin, metformin, sulfonylureas)
Additive blood sugar lowering - hypoglycemia risk. 29 known drug interactions on Drugs.com (all minor). Relatively clean interaction profile compared to other supplements
Drugs.com 29 interactions listed; Examine.com ALA research page
Do NOT combine with:
Thyroid medications, immunosuppressants, sedatives
Animal studies: increased T4 by ~40%. Case reports of thyroid level changes in humans (2024). May stimulate immune function - opposes immunosuppressants. Additive sedation with CNS depressants
NCCIH ashwagandha safety review (2024); GoodRx 5 ashwagandha interactions; Examine.com ashwagandha research
Do NOT combine with:
SSRIs, SNRIs, MAOIs, Tramadol, Buspirone, clomipramine
Potent reversible MAO-A inhibitor at nanomolar concentrations. At least 14 published case reports of serotonin toxicity, 1 fatal. FDA safety communication issued October 2011
PMC2078225 (Gillman & Ramsay 2006 - first MAO-A inhibition demonstration); FDA Drug Safety Communication October 2011; PMC11089602
Do NOT combine with:
Metformin, insulin, other diabetes medications
Additive blood sugar lowering - hypoglycemia risk. Berberine may increase metformin levels when taken 2 hours before
GoodRx clinical review; PMID 35489323
Do NOT combine with:
Warfarin, clopidogrel, aspirin, anticoagulants
Antiplatelet effect increases bleeding risk. Case report: INR rose above 10 in a patient on warfarin after starting turmeric
PMID 22531131; Medsafe NZ alert 2018
Do NOT combine with:
Warfarin, blood pressure medications
May reduce warfarin effectiveness (structurally similar to vitamin K). May enhance blood pressure medication effects
PMID 17482884; AHA/ACC guidance
Do NOT combine with:
NSAIDs (long-term), diuretics, nephrotoxic drugs
Theoretical kidney stress with nephrotoxic drugs. Dehydration risk with diuretics. May cause false-positive on kidney function tests (elevated creatinine)
Drugs.com interaction checker; DrugBank DB00148
Do NOT combine with:
Blood pressure medications, immunosuppressants, sedatives, anticoagulants
Enhances blood pressure lowering (hypotension risk). Stimulates immune function - may counteract immunosuppressants. Additive sedation with CNS depressants
Mayo Clinic drug interactions; GoodRx 9 interactions guide
Do NOT combine with:
Anticoagulants, antiplatelet drugs
Inhibits collagen-induced platelet aggregation - slows blood clotting. Additive bleeding risk with blood thinners
WebMD lion's mane interactions; in vitro platelet studies
Do NOT combine with:
Cyclosporine, antibiotics (fluoroquinolones), CYP3A4-metabolized drugs
Alters cyclosporine levels (both increases and decreases reported). Inhibits CYP3A4 and P-glycoprotein - may increase levels of many drugs
PMID 21466223; PMC5042751
Do NOT combine with:
Immunosuppressants (cyclosporine, tacrolimus, azathioprine), chemotherapy
Risk of bacteremia or fungemia in immunocompromised patients. Live organisms can cross gut barrier when immune system is suppressed
PMID 26287986; Frontiers in Neuroscience review
Do NOT combine with:
Fluoroquinolones, tetracyclines, penicillamine, bisphosphonates
Chelation reduces absorption of both zinc and the antibiotic. Reduces penicillamine absorption
NIH ODS zinc fact sheet; Drugs.com interaction checker
Do NOT combine with:
Cisplatin, barbiturates, blood thinners
May reduce cisplatin effectiveness. Additive sedation with barbiturates. Mild anticoagulant effect at high doses
NIH ODS selenium fact sheet; WebMD selenium interactions
Do NOT combine with:
Thyroid medications, amitriptyline, CYP1A2/2C9/2C19/3A4-metabolized drugs
Inhibits CYP1A2, 2C9, 2C19, 3A4. Increases amitriptyline levels in animal studies. May increase thyroid hormone levels (T4 by ~40% in animal models)
PMC6271976; SciELO Brazil amitriptyline study; Examine.com bacopa FAQ
Do NOT combine with:
MAOIs, SSRIs, SNRIs, antihypertensives, CYP2C9/3A4-metabolized drugs
MAO inhibitory activity - serotonin syndrome risk with serotonergic drugs. Potent CYP3A4, CYP2D6, and P-gp inhibition. Additive blood pressure lowering
PMID 25413939 (case report); PMC9881059; MSKCC rhodiola monograph
Do NOT combine with:
Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine), scopolamine
Excessive acetylcholine accumulation with AChE inhibitors - GI upset, bradycardia, urinary issues. Opposes scopolamine effects
PMID 1662399; ADDF cognitive vitality review
Do NOT combine with:
Anticoagulants (warfarin, heparin), antiplatelet drugs
Enhances heparin anticoagulant effect. Mild anticoagulant properties may increase bleeding risk with blood thinners
PMID 7314577; Cleveland Clinic PS monograph; RxList
Do NOT combine with:
Blood pressure medications, sedatives, benzodiazepines
Additive blood pressure lowering with antihypertensives. Mild additive sedation with CNS depressants
WebMD theanine interactions; PMC3518171
Do NOT combine with:
Methotrexate, phenytoin, carbamazepine, valproic acid
May reduce methotrexate effectiveness. Anticonvulsants interfere with folate metabolism - may need higher doses. 25 known drug interactions (3 major)
Drugs.com 25 interactions; DrugBank DB04789
Do NOT combine with:
Metformin, PPIs (omeprazole), colchicine, chloramphenicol
Not a dangerous interaction - these drugs DEPLETE B12. Metformin impairs B12 absorption. PPIs reduce gastric acid needed for B12 release. Combined metformin + PPI significantly increases deficiency risk
PMC3507616; MHRA 2024 guidance; PMID Jung 2025
Do NOT combine with:
Warfarin, estrogen/HRT, chemotherapy, aluminum-containing antacids
High doses may reduce warfarin effectiveness. Increases estrogen levels (HRT side effects). May interfere with chemotherapy. Increases aluminum absorption with antacids
PMC11082382; Mayo Clinic vitamin C; GoodRx interactions
Do NOT combine with:
Lithium, ACE inhibitors, potassium-sparing diuretics
Sodium changes alter lithium clearance - toxicity risk. Potassium supplements + ACE inhibitors + spironolactone = dangerous hyperkalemia (K+ rose 1.2 mmol/L in studies). Sodium loading counters diuretic effects
PMID 8521679; PMC4955086; PMC7358048
Do NOT combine with:
Warfarin, acenocoumarol, thyroid medications, anticonvulsants
Increases anticoagulant effect of warfarin/acenocoumarol. May decrease thyroid hormone effectiveness. May lower seizure threshold in people with seizure history
WebMD ALCAR interactions; RxList ALCAR precautions; DrugBank DB08842
Do NOT combine with:
SSRIs/SNRIs (serotonin risk above 100mg/day), anticoagulants, antihypertensives
At 30mg/day: clinical trials show safe with SSRIs. Above 100mg/day: increased serotonergic load. Anticoagulant properties - case report of bleeding with rivaroxaban. Additive blood pressure lowering
PMC11426294 (saffron in depression comparative review); WebMD saffron interactions; rivaroxaban case report
Do NOT combine with:
SSRIs, SNRIs, MAOIs, clomipramine, tramadol, meperidine, levodopa
Increases serotonin levels - serotonin syndrome risk with serotonergic drugs. Methylates levodopa, reducing its effectiveness in Parkinson's disease. AVOID with MAOIs
Mayo Clinic SAMe guidance; NCCIH SAMe monograph; PMID 20595412 (SAMe + SSRI RCT); Merck Manual SAMe
Do NOT combine with:
Diabetes medications (insulin, metformin, sulfonylureas), hormone-sensitive cancer treatments
May lower blood sugar - hypoglycemia risk with diabetes meds. CYP450 enzyme interactions possible. Increases testosterone - contraindicated in hormone-sensitive cancers (prostate, breast)
RxList tongkat ali interactions; NCBI LiverTox NBK609015; WebMD tongkat ali
Do NOT combine with:
Warfarin, methadone, statins (atorvastatin), chemotherapy agents
In vitro CYP2C9 and CYP3A4 inhibition, but clinical studies show minimal effect at standard doses. Sensitive drugs (warfarin, opioids, anti-arrhythmics) still warrant caution. Chemotherapy interactions require oncologist supervision
PMC4164972 (CYP450 clinical study - no significant effect); Pharmacy Times milk thistle interactions; Mayo Clinic milk thistle
Do NOT combine with:
Lithium, diabetes medications (may have additive glucose-lowering effect)
Lithium may interfere with inositol signaling (lithium depletes inositol - this is part of its mechanism). Metformin and myo-inositol may have additive insulin-sensitizing effects - monitor blood glucose
PMC5655679 (myo-inositol PCOS meta-analysis); MDPI comparative study with metformin
Do NOT combine with:
Anticoagulants, iron/zinc/copper supplements, diabetes medications
Anticoagulant activity from carvacrol/thymol - increased bleeding risk. Reduces absorption of iron, zinc, copper (take 2h apart). May lower blood sugar (hypoglycemia risk with diabetes meds). Case report of hemorrhagic risk (2025)
PMID 39793412 (2025 hemorrhagic risk case report); WebMD oregano interactions; StyleCraze oregano oil side effects
Do NOT combine with:
Warfarin, anticoagulants, antiplatelet drugs, chemotherapy
Inhibits vitamin K-dependent clotting factors and platelet aggregation. Risk mainly at >400 IU/day. Standard multivitamin doses (15-30mg) are safe. May interfere with some chemotherapy mechanisms
PMID 8629604 (vitamin E + warfarin); PMC3886776 (vitamin E serum levels and bleeding); Cambridge nutrition reviews molecular basis
Do NOT combine with:
Warfarin, other vitamin K antagonist anticoagulants
Directly opposes warfarin. Doses as low as 10mcg MK-7 significantly influenced anticoagulation in some individuals. Dose-dependent antagonism of warfarin. DOACs (apixaban, rivaroxaban) are NOT affected because they block different clotting pathways
PMID 23530987 (MK-7 dose-response in anticoagulation); PMC4972987 (K2 and warfarin perioperative); Blood ASH vitamin K supplementation caution
Do NOT combine with:
No direct drug interactions - but causes DANGEROUS lab test interference
FDA warning: high-dose biotin (5000-10000mcg) falsifies thyroid tests, troponin, hormones, and other biotin-streptavidin-based assays. Can mimic Graves disease on labs. One death reported from missed heart attack due to falsely low troponin
PMC5951654 (biotin lab interference); PMC6663274 (thyroid bioassay case series); PMC6802814 (FDA warning case report); AACC guidance document
Do NOT combine with:
Acetylcholinesterase inhibitors (donepezil, rivastigmine), atropine
May increase acetylcholine levels - additive effect with AChE inhibitors. Gut bacteria convert choline to TMA/TMAO (associated with cardiovascular risk at high supplemental doses). Opposes atropine effects
NIH ODS choline fact sheet; HelloPharmacist choline interactions; PMC8410632 (choline supplements raise TMAO)
Do NOT combine with:
Thyroid medications (levothyroxine, methimazole), lithium, amiodarone
Excess iodine can cause hyper- OR hypothyroidism depending on underlying thyroid status. Lithium + iodine = additive hypothyroid effect. Amiodarone already contains 37.5% iodine by weight - supplemental iodine is dangerous. Jod-Basedow disease risk in multinodular goiter
PMC1070767 (medications affecting thyroid); PMC3028253 (iodine-induced hyperthyroidism); WebMD iodine interactions; Drugs.com iodine + levothyroxine
Do NOT combine with:
Doxorubicin (chemotherapy), anticholinergic drugs, tetracycline
Minimal drug interactions at standard doses. May affect doxorubicin effectiveness. Anticholinergic drugs may reduce riboflavin absorption. Generally one of the safest supplements
Drugs.com riboflavin interactions; NIH ODS riboflavin fact sheet
Do NOT combine with:
No significant drug interactions at supplemental doses
Extremely safe. No known clinically significant drug interactions. Water-soluble - excess is excreted. High-dose IV thiamine can rarely cause anaphylaxis but oral is safe
Drugs.com thiamine interactions (no significant interactions listed); NIH ODS thiamine fact sheet
Do NOT combine with:
Levothyroxine, antibiotics (tetracyclines, quinolones), bisphosphonates, iron
Chelation reduces absorption of thyroid medication, antibiotics, bisphosphonates, and iron. Separate all by 2-4 hours. Thiazide diuretics + calcium + vitamin D = hypercalcemia risk
PMC8002057 (levothyroxine interaction review); Drugs.com calcium interactions
Do NOT combine with:
Estrogen, hormone replacement therapy
May increase estrogen levels. Generally safe at doses under 20mg/day. Limited drug interaction data
WebMD boron interactions; NIH ODS boron fact sheet
Do NOT combine with:
Diabetes medications (insulin, metformin, sulfonylureas), levothyroxine
Additive blood sugar lowering with diabetes meds - hypoglycemia risk. May reduce levothyroxine absorption (take 4h apart). Generally well-tolerated at doses under 1000mcg/day
WebMD chromium interactions; Drugs.com chromium picolinate interactions
Do NOT combine with:
Diabetes medications (insulin, oral hypoglycemics)
May lower blood sugar - additive hypoglycemia risk with diabetes medications. Limited interaction data
WebMD D-ribose interactions; RxList D-ribose precautions
Do NOT combine with:
No significant drug interactions known
Breaks down dietary histamine in the gut. Does not enter systemic circulation. No known CYP interactions. One of the safest supplements for medication co-administration
PMID 31807350 (DAO supplementation trial); Drugs.com DAO interactions
Do NOT combine with:
Blood thinners (bromelain component), acarbose
Bromelain (in some enzyme blends) has mild antiplatelet activity. May reduce effectiveness of acarbose (alpha-glucosidase inhibitor). Otherwise very safe
WebMD digestive enzymes interactions; Drugs.com bromelain interactions
Do NOT combine with:
Clozapine (antipsychotic)
Extremely safe amino acid. Only known interaction: may affect clozapine levels. No CYP interactions. Used as a sleep aid at 3g before bed
WebMD glycine interactions; Drugs.com glycine interactions
Do NOT combine with:
CYP1A2 substrates (caffeine, clozapine), CYP3A4 substrates, sedatives
In vitro CYP1A2 and CYP3A4 inhibition. Additive sedation with CNS depressants. Clinical significance at supplement doses is unclear
WebMD chamomile interactions; Examine.com apigenin research
Do NOT combine with:
Chemotherapy (may reduce effectiveness), nitroglycerin (potentiates vasodilation similar to NAC)
As the body's master antioxidant, may theoretically reduce oxidative-stress-dependent chemotherapy effectiveness. Potentiates nitroglycerin like NAC. Otherwise very safe with minimal drug interactions
Drugs.com glutathione interactions; clinical pharmacology references
Do NOT combine with:
Anticoagulants (warfarin, aspirin), diabetes medications
Mild antiplatelet activity - additive bleeding risk with blood thinners at high doses. May lower blood sugar. Standard culinary doses are safe; supplement doses (500-1000mg) warrant more caution
WebMD ginger interactions; Drugs.com ginger interactions
Do NOT combine with:
Sedatives, CNS depressants, CYP3A4-metabolized drugs
Additive sedation with benzodiazepines, Z-drugs, alcohol. Silexan (standardized lavender oil) has anxiolytic effects comparable to low-dose lorazepam. Potential CYP3A4 interaction
Drugs.com lavender interactions; Gaiaherbs lavender safety; Examine.com lavender research
Do NOT combine with:
CYP3A4-metabolized drugs (theoretical), anticoagulants
In vitro CYP inhibition but limited clinical data on drug interactions. Mild antiplatelet properties. Primarily studied for mast cell stabilization in MCAS
PMID 26190965 (Theoharides mast cell/neuroscience); WebMD luteolin interactions
Do NOT combine with:
No significant drug interactions known
Endogenous fatty acid amide - the body already produces PEA. No known CYP interactions. No serotonergic activity. One of the cleanest supplement interaction profiles available
PMID 27220803 (PEA review); Drugs.com PEA interactions
Do NOT combine with:
CYP1A2 substrates (caffeine, theophylline), thyroid medications (goitrogenic at extreme doses)
Induces Phase 2 detoxification enzymes (NRF2 pathway). May affect CYP1A2 metabolism. Cruciferous compounds are mildly goitrogenic in iodine-deficient individuals - not clinically significant at supplement doses
Examine.com sulforaphane research; WebMD broccoli sprout interactions
Do NOT combine with:
Warfarin (contains vitamin K), immunosuppressants
Contains vitamin K - may reduce warfarin effectiveness. May stimulate immune function - opposes immunosuppressants. Heavy metal binding properties (used as detox binder)
WebMD chlorella interactions; Drugs.com chlorella interactions
Do NOT combine with:
Iron supplements (tanins reduce absorption), diabetes medications
Anti-androgenic properties (used therapeutically in PCOS for hirsutism). Tannins reduce iron absorption. May have mild blood sugar lowering effect. Very safe overall
WebMD spearmint interactions; PCOS spearmint tea studies
Do NOT combine with:
Lactulose (hepatic encephalopathy), anticonvulsants
Converted to glutamate in the body - may theoretically worsen hepatic encephalopathy (opposes lactulose mechanism). May affect anticonvulsant threshold via glutamate. Otherwise very safe amino acid
WebMD L-glutamine interactions; Drugs.com L-glutamine interactions
Do NOT combine with:
Calcium supplements (increases calcium absorption), aminoglycoside antibiotics
Increases calcium absorption - monitor if already taking high-dose calcium. May increase aminoglycoside toxicity (rare). Otherwise very safe amino acid with minimal interactions
WebMD lysine interactions; Drugs.com L-lysine interactions
Do NOT combine with:
Blood pressure medications, nitrates (nitroglycerin, sildenafil), anticoagulants
Vasodilator - additive blood pressure lowering with antihypertensives. Potentiates nitrate effects (dangerous hypotension with nitroglycerin or sildenafil). Mild antiplatelet activity
WebMD L-arginine interactions; Mayo Clinic L-arginine guidance; Drugs.com L-arginine interactions
Do NOT combine with:
Blood pressure medications, diabetes medications, anticoagulants, lithium, sedatives
May lower blood pressure and blood sugar. Diuretic effect may affect lithium levels. Mild anticoagulant properties. Additive sedation
WebMD stinging nettle interactions; PMID 2189951 (Mittman 1990 allergic rhinitis RCT)
Do NOT combine with:
See individual B vitamins (B1, B2, B6, B12, folate). Biotin component causes lab interference. B6 >100mg/day long-term can cause neuropathy
Standard B-complex doses are very safe. High-dose biotin component can falsify lab tests. High-dose B6 (>100mg/day for months) causes peripheral neuropathy. Methylated forms bypass MTHFR variants
PMC5951654 (biotin lab interference); NIH ODS B-vitamin fact sheets
Do NOT combine with:
No significant drug interactions
GI upset (diarrhea, cramping) is the main side effect, especially when starting. No known CYP interactions. Safe with essentially all medications. Start low (1 tsp) and increase gradually
WebMD MCT oil interactions; Drugs.com MCT oil interactions
Do NOT combine with:
Anticoagulants, CYP3A4/CYP1A2-metabolized drugs, estrogen
Resveratrol has antiplatelet properties - additive bleeding risk. Inhibits CYP3A4 and CYP1A2 in vitro. Phytoestrogenic - may affect hormone-sensitive conditions. Herxheimer reactions possible at antimicrobial doses (Lyme protocol)
PMID 32154254 (Johns Hopkins anti-borrelial study); WebMD resveratrol interactions
Do NOT combine with:
Anticoagulants, antihypertensives, immunosuppressants, CYP3A4-metabolized drugs
Antiplatelet activity. Lowers blood pressure. Immunostimulant - opposes immunosuppressants. CYP3A4 inhibition. Interacts with anticoagulants and antihypertensives
PMID 15649507 (anti-borrelial); PMID 32154254 (Johns Hopkins); WebMD cat's claw interactions
Do NOT combine with:
ALL oral medications (binders reduce absorption of everything)
Non-selective binding - activated charcoal and clay bind medications, supplements, and nutrients indiscriminately. MUST separate from all other oral medications by 2-4 hours. Cholestyramine is prescription and has specific interaction warnings
Drugs.com activated charcoal interactions; FDA cholestyramine label; Clinical toxicology references
Do NOT combine with:
No significant drug interactions known
Soluble prebiotic fiber. May slightly slow absorption of co-administered medications. Does not bind medications like charcoal. Very safe with all drugs
PMID 21050236 (Furnari rifaximin + PHGG trial); Drugs.com guar gum interactions
Do NOT combine with:
See individual entries for Berberine and Oregano Oil. Combined: additive blood sugar lowering, anticoagulant effects, and CYP interactions
The combination amplifies individual risks. Berberine CYP3A4/2D6 interactions + oregano oil anticoagulant/mineral chelation. Monitor more closely than with either alone
PMID 14894990 (Chedid herbal vs rifaximin SIBO trial); Combined risk profile from individual entries
Do NOT combine with:
Cyclosporine (CYP3A4 inhibition), antacids/PPIs (dissolve enteric coating prematurely), iron supplements
CYP3A4 inhibition may increase cyclosporine levels. Antacids/PPIs dissolve enteric coating, causing heartburn and reduced gut-level delivery. May reduce iron absorption. Enteric coating is essential - non-coated causes GERD
WebMD peppermint oil interactions; Drugs.com peppermint interactions
Do NOT combine with:
CYP1A2/CYP2C19 substrates, statins, hepatotoxic drugs, sedatives
Wogonin component inhibits CYP1A2 and CYP2C19. Decreased statin levels in healthy volunteers. Case reports of acute liver injury (hepatotoxicity). Limited safety data - mostly used in Bartonella protocols (Buhner)
PMID 33711551 (drug-herb interaction review); PMID 30957370 (liver injury case report); MSKCC scutellaria monograph
Do NOT combine with:
Limited data - caution with CYP-metabolized drugs, antidiabetic medications, antimalarials
Very limited published interaction data. Traditional antimalarial - may interact with antimalarial drugs. Contains cryptolepine which has blood sugar lowering effects. Primarily studied for antimicrobial activity against Borrelia and Babesia. NO well-characterized drug interaction profile
Limited published data. Used in Buhner/Zhang Bartonella protocols. No Drugs.com or Examine.com entry exists. Exercise caution
Do NOT combine with:
May attenuate CYP induction by other drugs (phenobarbital studied). No major known drug interactions
Short-chain fatty acid normally produced by gut bacteria. Supplemental form generally well-tolerated. Animal research shows butyrate may attenuate CYP2H and CYP3A induction - could theoretically affect drug metabolism but clinical significance is unclear. Crosses blood-brain barrier. HDAC inhibitor properties
PMC4903954 (butyrate neuroepigenetics); PMC10359501 (SCFAs gut-brain review); PMID 26614344 (butyrate CYP interaction animal study)
Table 2: Medications That Cause Brain Fog
Important: Do not discontinue medications without medical guidance. Discuss alternatives with your prescriber if you suspect medication-induced brain fog.
| Medication | Class | Mechanism | Risk | Alternative |
|---|---|---|---|---|
| Diphenhydramine (Benadryl) | 1st-gen antihistamine | Blocks acetylcholine - high ACB score (3). Crosses blood-brain barrier. Dementia risk with cumulative use AGS 2023 Beers Criteria (PMC12478568); betterhealthwhileaging.net brain-slowing medications | HIGH | Switch to cetirizine/loratadine (2nd-gen, minimal CNS penetration) |
| Oxybutynin (Ditropan) | Anticholinergic | Blocks muscarinic receptors in hippocampus. ACB score 3. Beers Criteria: avoid in older adults AGS 2023 Beers Criteria (PMC12478568) | AVOID | Discuss mirabegron (Myrbetriq) - beta-3 agonist, no anticholinergic burden |
| Zolpidem (Ambien) | Z-drug sleep aid | Same GABA pathways as benzodiazepines. Amnesia, parasomnia, next-day cognitive impairment AGS 2023 Beers Criteria; FDA boxed warning for complex sleep behaviors | HIGH | CBT-I first, then low-dose trazodone or suvorexant |
| Metoprolol / Atenolol | Beta-blocker (lipophilic) | Lipophilic - crosses BBB readily. Dampens norepinephrine, causes fatigue and cognitive dulling EBSCO beta-blocker drug interactions review | MODERATE | Discuss hydrophilic alternatives (nebivolol, bisoprolol cross BBB less) |
| SSRIs (class) | Antidepressant | Emotional blunting in 40-60% of patients. Paroxetine worst (anticholinergic). Individual variation significant - see specific SSRI entries below PMC neuropsychiatric review; individual SSRI entries in medication interactions table | MODERATE | Discuss bupropion, vortioxetine (pro-cognitive), or dose reduction |
| Alprazolam / Lorazepam | Benzodiazepine | Dampens working-to-long-term memory transfer. Dependence develops in 2-4 weeks. Withdrawal can be life-threatening AGS 2023 Beers Criteria; FDA benzodiazepine boxed warning | AVOID | Buspirone (non-addictive), hydroxyzine (short-term), CBT for anxiety |
| Gabapentin / Pregabalin | Anticonvulsant / nerve pain | Calcium channel modulation, cognitive dulling, dizziness, somnolence. Dose-dependent cognitive effects Drugs.com gabapentin interactions; FDA pregabalin label | MODERATE | Discuss dose reduction. Duloxetine or amitriptyline alternatives for neuropathic pain (trade-off: own side effects) |
| Omeprazole / Pantoprazole | PPI | Long-term B12 and magnesium depletion. Combined PPI + metformin dramatically increases B12 deficiency risk PMC3507616 (B12 deficiency with PPI + metformin); PMID Jung 2025 (concomitant use risk) | MODERATE | Step down to H2 blockers (famotidine) if possible. Supplement B12 and magnesium with chronic use |
| Amitriptyline / Nortriptyline | Tricyclic antidepressant | Highly anticholinergic - blocks acetylcholine in hippocampus. Beers Criteria: avoid in older adults. Memory impairment documented after 4 weeks AGS 2023 Beers Criteria (PMC12478568); Amitriptyline memory impairment (Springer BF02245119) | HIGH | SSRIs (sertraline, escitalopram) or SNRIs with lower anticholinergic burden |
| Paroxetine (Paxil) | SSRI (high anticholinergic) | Most anticholinergic SSRI - uniquely problematic for cognition compared to other SSRIs. On Beers Criteria. Also strongest CYP2D6 inhibitor among SSRIs AGS 2023 Beers Criteria (PMC12478568); PharmD Live anticholinergic Beers review | HIGH | Switch to sertraline or escitalopram (lower anticholinergic burden) |
| Topiramate (Topamax) | Anticonvulsant / migraine preventive | Up to 40% experience cognitive deficits. Word-finding difficulty, slowed processing, impaired working memory. Nicknamed 'Dopamax'. Each ug/mL plasma concentration reduces memory accuracy by 3.6% PMC4110841 (cognitive impairment evidence review); PMC7572737 (working memory dose-response); Pharmacy Times language impairment | HIGH | Discuss propranolol, candesartan, or CGRP inhibitors for migraine prevention |
| Cyclobenzaprine (Flexeril) | Muscle relaxant | Structurally identical to tricyclic antidepressants. Strong anticholinergic, antihistamine, and sedative effects. Impairs driving vs placebo in controlled study PMID 32390248 (tolperisone vs cyclobenzaprine driving/cognition RCT); StatPearls NBK513362; AAFP muscle relaxant review | HIGH | Methocarbamol (less sedating) or metaxalone (least sedating). Tolperisone showed no cognitive impairment vs placebo |
| Quetiapine (Seroquel) | Atypical antipsychotic | Strong antihistamine and anticholinergic properties. Somnolence in up to 57%. Worse cognitive performance than risperidone on 9/18 cognitive measures in crossover study PMID 17854242 (risperidone vs quetiapine cognitive comparison); Drugs.com quetiapine brain fog reports | HIGH | Discuss dose reduction, bedtime-only dosing, or alternative if used off-label for sleep |
| Opioids (codeine, tramadol, oxycodone, morphine) | Opioid analgesic | Impairs attention, memory, language, processing speed. 20% higher MCI risk with regular use. Effects worsen >120mg morphine equivalent/day. May persist during pharmacotherapy PMC4776316 (prospective cohort - dementia risk); PMC8437064 (opioid cognitive function); Alzheimer's & Dementia Lin 2025 (UK Biobank) | HIGH | Non-opioid pain management: NSAIDs, PEA, physical therapy, nerve blocks. Discuss tapering plan |
| Prednisone / Corticosteroids | Glucocorticoid | Declarative memory deficits emerge within 4-5 days. Psychiatric symptoms rare at <40mg/day but 18.4% at >80mg/day. Affects hippocampus and prefrontal cortex. Reversible in most cases PMC181154 (mood and cognitive changes review); Mayo Clinic Proceedings psychiatric adverse effects; Bristol 2023 long-term steroid study | MODERATE | Use lowest effective dose. Steroid-sparing agents where possible. Cognitive effects generally reversible within months |
| Scopolamine patches | Anticholinergic | Potent central anticholinergic - causes confusion, memory impairment, and delirium especially in older adults. ACB score 3 AGS 2023 Beers Criteria (PMC12478568) | AVOID | Ondansetron (Zofran) for nausea. Meclizine for motion sickness (less CNS penetration) |
| Olanzapine (Zyprexa) | Atypical antipsychotic | High anticholinergic and antihistamine burden. Weight gain compounds metabolic fog. Sedation and cognitive dulling common JAMA Psychiatry CATIE trial neurocognitive effects | HIGH | Discuss aripiprazole (lower metabolic/sedation burden) if appropriate |
| Vortioxetine (Trintellix) | Antidepressant (pro-cognitive) | POSITIVE: Only antidepressant with RCT evidence for cognitive improvement independent of mood. Multimodal serotonin modulator FDA Trintellix label; depression.json cause page references | LOW | This IS the alternative - discuss switching if other antidepressants cause fog |
| Bupropion (Wellbutrin) | Antidepressant (pro-cognitive) | POSITIVE: Norepinephrine-dopamine reuptake inhibitor. Less sedation, less sexual dysfunction, less cognitive blunting than SSRIs. Mildly activating FDA Wellbutrin label; GoodRx bupropion profile | LOW | This IS the alternative - discuss switching if SSRIs cause fog. Avoid if seizure risk or eating disorder |
1st-gen antihistamine
Blocks acetylcholine - high ACB score (3). Crosses blood-brain barrier. Dementia risk with cumulative use
Alternative: Switch to cetirizine/loratadine (2nd-gen, minimal CNS penetration)
AGS 2023 Beers Criteria (PMC12478568); betterhealthwhileaging.net brain-slowing medications
Anticholinergic
Blocks muscarinic receptors in hippocampus. ACB score 3. Beers Criteria: avoid in older adults
Alternative: Discuss mirabegron (Myrbetriq) - beta-3 agonist, no anticholinergic burden
AGS 2023 Beers Criteria (PMC12478568)
Z-drug sleep aid
Same GABA pathways as benzodiazepines. Amnesia, parasomnia, next-day cognitive impairment
Alternative: CBT-I first, then low-dose trazodone or suvorexant
AGS 2023 Beers Criteria; FDA boxed warning for complex sleep behaviors
Beta-blocker (lipophilic)
Lipophilic - crosses BBB readily. Dampens norepinephrine, causes fatigue and cognitive dulling
Alternative: Discuss hydrophilic alternatives (nebivolol, bisoprolol cross BBB less)
EBSCO beta-blocker drug interactions review
Antidepressant
Emotional blunting in 40-60% of patients. Paroxetine worst (anticholinergic). Individual variation significant - see specific SSRI entries below
Alternative: Discuss bupropion, vortioxetine (pro-cognitive), or dose reduction
PMC neuropsychiatric review; individual SSRI entries in medication interactions table
Benzodiazepine
Dampens working-to-long-term memory transfer. Dependence develops in 2-4 weeks. Withdrawal can be life-threatening
Alternative: Buspirone (non-addictive), hydroxyzine (short-term), CBT for anxiety
AGS 2023 Beers Criteria; FDA benzodiazepine boxed warning
Anticonvulsant / nerve pain
Calcium channel modulation, cognitive dulling, dizziness, somnolence. Dose-dependent cognitive effects
Alternative: Discuss dose reduction. Duloxetine or amitriptyline alternatives for neuropathic pain (trade-off: own side effects)
Drugs.com gabapentin interactions; FDA pregabalin label
PPI
Long-term B12 and magnesium depletion. Combined PPI + metformin dramatically increases B12 deficiency risk
Alternative: Step down to H2 blockers (famotidine) if possible. Supplement B12 and magnesium with chronic use
PMC3507616 (B12 deficiency with PPI + metformin); PMID Jung 2025 (concomitant use risk)
Tricyclic antidepressant
Highly anticholinergic - blocks acetylcholine in hippocampus. Beers Criteria: avoid in older adults. Memory impairment documented after 4 weeks
Alternative: SSRIs (sertraline, escitalopram) or SNRIs with lower anticholinergic burden
AGS 2023 Beers Criteria (PMC12478568); Amitriptyline memory impairment (Springer BF02245119)
SSRI (high anticholinergic)
Most anticholinergic SSRI - uniquely problematic for cognition compared to other SSRIs. On Beers Criteria. Also strongest CYP2D6 inhibitor among SSRIs
Alternative: Switch to sertraline or escitalopram (lower anticholinergic burden)
AGS 2023 Beers Criteria (PMC12478568); PharmD Live anticholinergic Beers review
Anticonvulsant / migraine preventive
Up to 40% experience cognitive deficits. Word-finding difficulty, slowed processing, impaired working memory. Nicknamed 'Dopamax'. Each ug/mL plasma concentration reduces memory accuracy by 3.6%
Alternative: Discuss propranolol, candesartan, or CGRP inhibitors for migraine prevention
PMC4110841 (cognitive impairment evidence review); PMC7572737 (working memory dose-response); Pharmacy Times language impairment
Muscle relaxant
Structurally identical to tricyclic antidepressants. Strong anticholinergic, antihistamine, and sedative effects. Impairs driving vs placebo in controlled study
Alternative: Methocarbamol (less sedating) or metaxalone (least sedating). Tolperisone showed no cognitive impairment vs placebo
PMID 32390248 (tolperisone vs cyclobenzaprine driving/cognition RCT); StatPearls NBK513362; AAFP muscle relaxant review
Atypical antipsychotic
Strong antihistamine and anticholinergic properties. Somnolence in up to 57%. Worse cognitive performance than risperidone on 9/18 cognitive measures in crossover study
Alternative: Discuss dose reduction, bedtime-only dosing, or alternative if used off-label for sleep
PMID 17854242 (risperidone vs quetiapine cognitive comparison); Drugs.com quetiapine brain fog reports
Opioid analgesic
Impairs attention, memory, language, processing speed. 20% higher MCI risk with regular use. Effects worsen >120mg morphine equivalent/day. May persist during pharmacotherapy
Alternative: Non-opioid pain management: NSAIDs, PEA, physical therapy, nerve blocks. Discuss tapering plan
PMC4776316 (prospective cohort - dementia risk); PMC8437064 (opioid cognitive function); Alzheimer's & Dementia Lin 2025 (UK Biobank)
Glucocorticoid
Declarative memory deficits emerge within 4-5 days. Psychiatric symptoms rare at <40mg/day but 18.4% at >80mg/day. Affects hippocampus and prefrontal cortex. Reversible in most cases
Alternative: Use lowest effective dose. Steroid-sparing agents where possible. Cognitive effects generally reversible within months
PMC181154 (mood and cognitive changes review); Mayo Clinic Proceedings psychiatric adverse effects; Bristol 2023 long-term steroid study
Anticholinergic
Potent central anticholinergic - causes confusion, memory impairment, and delirium especially in older adults. ACB score 3
Alternative: Ondansetron (Zofran) for nausea. Meclizine for motion sickness (less CNS penetration)
AGS 2023 Beers Criteria (PMC12478568)
Atypical antipsychotic
High anticholinergic and antihistamine burden. Weight gain compounds metabolic fog. Sedation and cognitive dulling common
Alternative: Discuss aripiprazole (lower metabolic/sedation burden) if appropriate
JAMA Psychiatry CATIE trial neurocognitive effects
Antidepressant (pro-cognitive)
POSITIVE: Only antidepressant with RCT evidence for cognitive improvement independent of mood. Multimodal serotonin modulator
Alternative: This IS the alternative - discuss switching if other antidepressants cause fog
FDA Trintellix label; depression.json cause page references
Antidepressant (pro-cognitive)
POSITIVE: Norepinephrine-dopamine reuptake inhibitor. Less sedation, less sexual dysfunction, less cognitive blunting than SSRIs. Mildly activating
Alternative: This IS the alternative - discuss switching if SSRIs cause fog. Avoid if seizure risk or eating disorder
FDA Wellbutrin label; GoodRx bupropion profile
Table 3: I'm On This Medication - What Supplements Should I Watch?
51 medications with CYP enzyme profiles, supplement interaction details, and cognitive effect ratings. Find your medication below and see which supplements need timing separation, dose adjustment, or avoidance.
Metformin - Biguanide antidiabetic HIGH
(Glucophage, Glumetza, Fortamet)
CYP Metabolism
Not CYP-metabolized (renal elimination)
Cognitive Effect
neutral
Supplement Interactions
Berberine (additive hypoglycemia, increases metformin levels if taken 2h before), Alpha-Lipoic Acid (additive glucose lowering), Chromium (additive). DEPLETES: B12 (impairs IF-mediated absorption), possibly magnesium
Risk
Hypoglycemia with glucose-lowering supplements. B12 deficiency (57 pmol/L reduction after 4 months). Combined metformin + PPI dramatically increases B12 deficiency risk
What To Do
Monitor B12 annually. Take berberine WITH metformin (not 2h before). Use sublingual B12 to bypass absorption issue
394 drug interactions on Drugs.com (25 major). PMC7308123; PMC5839379; MHRA 2024 B12 monitoring guidance
Verify → Insulin (all forms) - Hormone HIGH
(Humalog, Novolog, Lantus, Levemir, Tresiba)
CYP Metabolism
Not CYP-metabolized (degraded by insulin-degrading enzyme)
Cognitive Effect
neutral (treats condition that causes fog)
Supplement Interactions
Berberine (additive hypoglycemia), Alpha-Lipoic Acid (additive glucose lowering), Chromium (additive), Magnesium (may improve insulin sensitivity). All glucose-lowering supplements require dose monitoring
Risk
Hypoglycemia - any supplement that lowers blood sugar adds to insulin's effect. Dose adjustments may be needed
What To Do
Monitor blood glucose more frequently when adding any glucose-lowering supplement. Start supplements at low dose
Drugs.com insulin interaction checker; WebMD berberine interactions
Verify → Semaglutide - GLP-1 receptor agonist MODERATE
(Ozempic, Wegovy, Rybelsus)
CYP Metabolism
Not significantly CYP-metabolized (proteolytic degradation)
Cognitive Effect
potentially pro-cognitive (neuroprotective signals in research)
Supplement Interactions
Delays gastric emptying - affects absorption timing of ALL oral supplements. Oral semaglutide (Rybelsus) specifically interacts with levothyroxine absorption
Risk
286 drug interactions (16 major). Main risk is altered absorption timing of oral medications and supplements, not direct pharmacological interaction
What To Do
Take oral supplements 30+ min before or 2h after injection. For Rybelsus: take on empty stomach with <4oz water, wait 30min before other medications
Drugs.com 286 interactions; FDA label 2024; Healthline Ozempic interactions
Verify → Tirzepatide - GIP/GLP-1 dual agonist MODERATE
(Mounjaro, Zepbound)
CYP Metabolism
Not significantly CYP-metabolized
Cognitive Effect
potentially pro-cognitive (dual incretin pathway)
Supplement Interactions
Same gastric emptying delay as semaglutide. Affects absorption of oral contraceptives, levothyroxine, and oral supplements
Risk
Altered absorption timing. Less studied than semaglutide for specific supplement interactions
What To Do
Take oral supplements and medications at consistent times. Separate from narrow-therapeutic-index drugs
FDA Mounjaro label; Drugs.com tirzepatide interactions
Verify → Empagliflozin / Dapagliflozin - SGLT2 inhibitor MODERATE
(Jardiance / Farxiga)
CYP Metabolism
UGT glucuronidation (not CYP-dependent)
Cognitive Effect
potentially neuroprotective (SGLT2i brain research emerging)
Supplement Interactions
Diuretic supplements (dandelion, hibiscus) increase dehydration risk. Electrolyte supplements may be needed (sodium, potassium loss). Ketogenic diet + SGLT2i = elevated ketoacidosis risk
Risk
Euglycemic diabetic ketoacidosis (rare but serious - 1 in 1,000-10,000). Dehydration and electrolyte imbalance. Risk factors: low carb intake, dehydration, infection
What To Do
Stay well-hydrated. Monitor electrolytes. Avoid very low carb diets without medical supervision. Know signs of ketoacidosis (nausea, vomiting, abdominal pain, fatigue)
PMC4773669; FDA DKA warning; GOV.UK SGLT2i ketoacidosis update
Verify → Levothyroxine - Thyroid hormone replacement TREATS FOG HIGH
(Synthroid, Levoxyl, Tirosint, Euthyrox)
CYP Metabolism
Deiodination (not CYP-dependent). Absorption is the critical variable
Cognitive Effect
treats fog (when absorption is adequate)
Supplement Interactions
Calcium (blocks absorption), Iron (blocks absorption), Magnesium (blocks absorption), Zinc (blocks absorption), Coffee (reduces absorption). ALL minerals must be separated 4+ hours. Soy and fiber also reduce absorption. Biotin can falsify thyroid lab results
Risk
Only 31.8% of patients told to separate minerals from levothyroxine by 4h, and only 40.7% of those actually do it. Undertreated hypothyroidism = brain fog
What To Do
Take levothyroxine on empty stomach 60min before breakfast. Separate ALL supplements 4h. Tirosint (gel cap) has fewer absorption interactions. Biotin: stop 48h before thyroid labs
PMC8002057 systematic review; Drugs.com levothyroxine interactions; 2024 Journal of the Endocrine Society
Verify → Liothyronine - T3 thyroid hormone TREATS FOG HIGH
(Cytomel)
CYP Metabolism
Deiodination (same as levothyroxine)
Cognitive Effect
treats fog (T3 is the active thyroid hormone)
Supplement Interactions
Same mineral chelation issues as levothyroxine - calcium, iron, magnesium all reduce absorption. Shorter half-life means timing is even more critical
Risk
Narrower therapeutic window than levothyroxine. Mineral interference has proportionally larger impact
What To Do
Same 4-hour separation rule. Take on empty stomach. More sensitive to timing than levothyroxine
Same absorption interaction profile as levothyroxine; FDA Cytomel label
Verify → Doxycycline - Tetracycline antibiotic HIGH
(Vibramycin, Doryx, Monodox)
CYP Metabolism
Minimal CYP metabolism (excreted unchanged in urine/feces)
Cognitive Effect
neutral (treats infection that may cause fog)
Supplement Interactions
Calcium (reduces absorption up to 30%), Magnesium (chelation), Iron (chelation), Zinc (chelation), Dairy products (calcium content). ALL minerals form insoluble complexes with doxycycline. Probiotics: separate 2h
Risk
Chelation reduces antibiotic absorption - undertreated infection. Critical for Lyme and Bartonella patients who are also taking mineral supplements
What To Do
Take doxycycline 2h BEFORE or 4-6h AFTER any mineral supplement. Take with water (not milk). Probiotics: 2h separation. Can take with non-dairy food to reduce GI upset
Drugs.com doxycycline interactions; Patient.info calcium interaction guide; PMC9660598 enteral supplement interactions
Verify → Rifaximin - Gut-specific antibiotic (rifamycin) TREATS FOG LOW
(Xifaxan)
CYP Metabolism
Minimal systemic absorption (<0.4%). P-glycoprotein substrate
Cognitive Effect
treats fog (SIBO treatment improves cognition)
Supplement Interactions
Cyclosporine (P-gp inhibitor) increases rifaximin blood levels 83-fold. Probiotics: reduced effectiveness if taken simultaneously (separate 2-3h). Warfarin: may alter vitamin K-producing gut bacteria, affecting INR
Risk
Generally very safe due to gut-local action. Main risk is P-gp inhibitor co-administration causing systemic absorption
What To Do
Take probiotics 2-3h after rifaximin. Avoid cyclosporine co-administration. Monitor INR if on warfarin
FDA Xifaxan label 2015; Healthline Xifaxan interactions; DrugBank DB01220; PMC8429411
Verify → Azithromycin - Macrolide antibiotic MODERATE
(Zithromax, Z-Pack)
CYP Metabolism
Minimal CYP metabolism (unlike erythromycin, does NOT significantly inhibit CYP3A4)
Cognitive Effect
neutral
Supplement Interactions
Magnesium and aluminum antacids reduce absorption. Probiotics: separate 2h. Less mineral chelation than tetracyclines but still avoid concurrent dosing with minerals
Risk
QT prolongation - avoid combining with supplements that affect heart rhythm. Generally fewer interactions than other macrolides
What To Do
Separate from antacids and mineral supplements by 2h. Take probiotics during and after course (2h separation). Complete full course
Drugs.com azithromycin interactions; FDA label QT warning
Verify → Metronidazole - Nitroimidazole antibiotic/antiprotozoal HIGH
(Flagyl)
CYP Metabolism
CYP2A6, CYP2C9 (partial)
Cognitive Effect
neutral (can cause temporary neurological symptoms at high doses)
Supplement Interactions
AVOID alcohol and alcohol-containing supplements (disulfiram-like reaction: nausea, vomiting, flushing). Warfarin (increased anticoagulant effect). Lithium (increased toxicity). Probiotics: take after completing course
Risk
Disulfiram-like reaction with alcohol is severe and well-documented. Avoid alcohol for 48h after last dose
What To Do
Absolutely no alcohol during and 48h after. Separate from warfarin timing. Check all tinctures/extracts for alcohol content
Drugs.com metronidazole interactions; FDA Flagyl label; PMID on disulfiram-like reaction
Verify → Methotrexate - DMARD / antimetabolite HIGH
(Trexall, Otrexup, Rasuvo)
CYP Metabolism
Renal elimination (not significantly CYP-metabolized). Displaced by NSAIDs at renal tubule
Cognitive Effect
can cause fog (methotrexate neurotoxicity at high doses)
Supplement Interactions
Folic acid (5mg weekly on different day - reduces toxicity without reducing efficacy). Methylfolate: may reduce methotrexate effectiveness (moderate interaction). NSAIDs: increase methotrexate toxicity by reducing renal clearance. Vitamin C: withhold 48-72h before high-dose MTX
Risk
25 drug interactions on Drugs.com (3 major). Renal toxicity amplified by NSAIDs. Folic acid supplementation is STANDARD of care - not optional
What To Do
Always co-prescribe folic acid 5mg weekly. Avoid NSAIDs. Avoid methylfolate without oncologist/rheumatologist approval. Vitamin C at standard doses (500mg) likely OK; withhold high doses before infusion
PMID 7978695; GoodRx 8 MTX interactions; NHS MTX interaction guidance; Chan 2025 Br J Clin Pharmacol
Verify → Hydroxychloroquine - DMARD / antimalarial TREATS FOG MODERATE
(Plaquenil)
CYP Metabolism
CYP2C8, CYP3A4, CYP2D6
Cognitive Effect
treats fog (by controlling autoimmune inflammation)
Supplement Interactions
Antacids (reduce absorption - separate 4h). Avoid immune-stimulating supplements (echinacea, spirulina, alfalfa) in lupus patients. Retinal toxicity risk increases with duration (7.5% at 5+ years, 20% at 20+ years)
Risk
Retinal toxicity is the major long-term risk - irreversible even after stopping. No specific supplement interaction is dangerous, but immune stimulants can trigger lupus flares
What To Do
Annual retinal screening after 5 years. Separate from antacids 4h. Avoid echinacea, spirulina, alfalfa in lupus. Zinc ionophore research is emerging for retinal protection
PMC10267834; AAO retinal toxicity guidelines; Drugs.com HCQ interactions
Verify → Azathioprine - Immunosuppressant / purine analog HIGH
(Imuran, Azasan)
CYP Metabolism
TPMT and XO (thiopurine methyltransferase, xanthine oxidase)
Cognitive Effect
can cause fog (bone marrow suppression, fatigue)
Supplement Interactions
AVOID live probiotics (bacteremia risk in immunosuppressed). Allopurinol (MAJOR - inhibits XO, dramatically increases azathioprine toxicity). Warfarin (reduced anticoagulant effect). Immune-stimulating supplements contraindicated
Risk
Live cultures can cause sepsis in immunosuppressed patients. Allopurinol co-administration requires 75% dose reduction of azathioprine
What To Do
No live probiotics. Use heat-killed postbiotics if gut support needed. Avoid echinacea, astragalus, and immune-boosting supplements
PMID 26287986; Drugs.com azathioprine interactions; FDA Imuran label
Verify → Mycophenolate - Immunosuppressant HIGH
(CellCept, Myfortic)
CYP Metabolism
UGT glucuronidation (not CYP-dependent)
Cognitive Effect
can cause fog (GI side effects, fatigue)
Supplement Interactions
Iron, calcium, magnesium, aluminum antacids (reduce absorption). AVOID live probiotics (sepsis risk). Cholestyramine (reduces levels). Proton pump inhibitors may reduce absorption of Myfortic
Risk
Mineral chelation similar to levothyroxine. Live organisms dangerous in immunosuppressed patients
What To Do
Separate minerals 2h. No live probiotics. Discuss with transplant team before ANY new supplement
Drugs.com mycophenolate interactions; FDA CellCept label
Verify → Cyclosporine - Calcineurin inhibitor AVOID
(Neoral, Sandimmune, Gengraf)
CYP Metabolism
CYP3A4 (major), P-glycoprotein substrate
Cognitive Effect
can cause fog (neurotoxicity at high levels)
Supplement Interactions
St. John's Wort (AVOID - CYP3A4 induction dramatically reduces levels). Quercetin (alters cyclosporine levels unpredictably). Grapefruit (CYP3A4 inhibition increases levels). Curcumin (CYP3A4 interaction). Rifaximin levels increase 83-fold with cyclosporine
Risk
Narrow therapeutic index - small changes in CYP3A4 activity cause transplant rejection (too low) or nephrotoxicity (too high). Most dangerous supplement interaction profile of any immunosuppressant
What To Do
AVOID all CYP3A4-affecting supplements. No St. John's Wort, no quercetin, no grapefruit. Discuss every supplement with transplant team. Drug level monitoring essential
PMC3913293; PMID 21466223 quercetin-cyclosporine; Drugs.com cyclosporine interactions
Verify → Methylphenidate - CNS stimulant PRO-COGNITIVE MODERATE
(Ritalin, Concerta, Focalin, Daytrana)
CYP Metabolism
Esterase hydrolysis (NOT CYP-dependent - fewer drug interactions than amphetamines)
Cognitive Effect
pro-cognitive (treats ADHD fog)
Supplement Interactions
Vitamin C / ascorbic acid: acidifies urine, may slightly reduce absorption. Less pH-sensitive than amphetamines. Caffeine: additive stimulation (cardiovascular risk). MAOIs: AVOID (hypertensive crisis)
Risk
Fewer supplement interactions than amphetamines because not CYP-metabolized. Main risks are additive stimulation and MAO-related hypertensive crisis
What To Do
Avoid high-dose vitamin C within 1h of dosing. Moderate caffeine. Never combine with MAOIs or MAOI-active supplements (rhodiola, high-dose St. John's Wort)
FDA Ritalin label; ContemporaryClinics CNS stimulant interactions; Drugs.com methylphenidate interactions
Verify → Amphetamine / Dextroamphetamine - CNS stimulant PRO-COGNITIVE HIGH
(Adderall, Vyvanse, Dexedrine)
CYP Metabolism
CYP2D6 (major). Renal elimination pH-dependent
Cognitive Effect
pro-cognitive (treats ADHD fog)
Supplement Interactions
Vitamin C (1000mg+) acts as an OFF switch - acidifies urine, dramatically increases amphetamine excretion. Sodium bicarbonate / alkalizing agents: increase amphetamine levels. Caffeine: additive cardiovascular stimulation. MAOIs: AVOID (hypertensive crisis)
Risk
pH-dependent elimination makes this uniquely sensitive to acid/base supplements. High-dose vitamin C can render medication ineffective
What To Do
Do NOT take vitamin C (1000mg+), citrus juice, or acidifying supplements within 1h before or after dosing. Avoid alkalizing agents. Moderate caffeine. Never combine with MAOIs or rhodiola
FDA Adderall label; Drugs.com vitamin C + Adderall interaction; ADDitude Magazine medication guide; PMID on pH-dependent elimination
Verify → Atomoxetine - Selective norepinephrine reuptake inhibitor (non-stimulant ADHD) PRO-COGNITIVE HIGH
(Strattera)
CYP Metabolism
CYP2D6 (major - poor metabolizers have 6-8x higher drug levels)
Cognitive Effect
pro-cognitive (treats ADHD fog)
Supplement Interactions
MAOIs: AVOID (hypertensive crisis - 14-day washout required). Strong CYP2D6 inhibitors increase atomoxetine levels 6-8x: fluoxetine, paroxetine, quinidine. Adjust dose if combining with CYP2D6 inhibitors
Risk
CYP2D6 poor metabolizers (5-10% of population) already have elevated levels. Any supplement inhibiting CYP2D6 can push levels dangerous
What To Do
Avoid supplements with MAO inhibition (rhodiola, high-dose St. John's Wort). If on fluoxetine or paroxetine, atomoxetine dose must be halved. Sertraline is safer to combine
NCBI Bookshelf NBK315951 CYP2D6 genotype; GoodRx top 4 atomoxetine interactions; FDA Strattera label
Verify → Guanfacine XR - Alpha-2 adrenergic agonist (non-stimulant ADHD) MODERATE
(Intuniv)
CYP Metabolism
CYP3A4 (major)
Cognitive Effect
can help focus but causes sedation
Supplement Interactions
CYP3A4 inhibitors (curcumin, grapefruit, quercetin) increase guanfacine levels. CYP3A4 inducers (St. John's Wort) decrease levels. CNS depressants (valerian, kava, melatonin) add to sedation
Risk
Sedation and hypotension are primary risks. CYP3A4 interactions can significantly alter blood levels
What To Do
Avoid grapefruit and strong CYP3A4-affecting supplements. Monitor blood pressure. Take at bedtime (sedating)
FDA Intuniv label; Drugs.com guanfacine interactions
Verify → Modafinil / Armodafinil - Eugeroic (wakefulness-promoting) PRO-COGNITIVE MODERATE
(Provigil / Nuvigil)
CYP Metabolism
CYP3A4 substrate and moderate inducer. Weak CYP2C19 inhibitor
Cognitive Effect
pro-cognitive (wakefulness, used off-label for MS/chemo fog)
Supplement Interactions
St. John's Wort (CYP3A4 induction - reduces modafinil levels). Caffeine (additive stimulation - anxiety, insomnia, palpitations). Hormonal contraceptives (CYP3A4 induction reduces effectiveness - use backup method). CYP3A4 inhibitors increase modafinil levels
Risk
CYP3A4 induction reduces efficacy of many co-administered drugs. Contraceptive failure is an underappreciated risk
What To Do
Avoid St. John's Wort. Moderate caffeine. Use backup contraception during and 1 month after modafinil. Take morning only (long half-life)
StatPearls NBK531476; PMC5809348 CYP cocktail study; Drugs.com modafinil interactions
Verify → Sertraline - SSRI TREATS FOG HIGH
(Zoloft)
CYP Metabolism
CYP2C19 (major), CYP2B6, CYP2D6
Cognitive Effect
treats depression fog but may cause emotional blunting
Supplement Interactions
5-HTP / L-tryptophan (AVOID - serotonin syndrome). St. John's Wort (AVOID - serotonin syndrome, CYP induction). Grapefruit juice (doubles sertraline levels via CYP3A4 inhibition). Rhodiola (MAO inhibition risk). Omega-3 may be synergistic
Risk
Serotonin syndrome is the primary danger. Case reports in elderly patients combining sertraline + St. John's Wort. Grapefruit juice increased plasma levels ~100% in a study of 8 subjects
What To Do
NEVER combine with 5-HTP, St. John's Wort, or rhodiola. Moderate grapefruit. Omega-3 is generally safe to combine. Tryptophan-rich foods (not supplements) are OK
PMC12420457; Drugs.com 5-HTP + Zoloft interaction; PeaceHealth sertraline interactions
Verify → Escitalopram - SSRI TREATS FOG MODERATE
(Lexapro)
CYP Metabolism
CYP2C19 (major), CYP3A4
Cognitive Effect
treats depression fog with relatively less blunting than paroxetine
Supplement Interactions
Same serotonergic risks as sertraline: AVOID 5-HTP, St. John's Wort, rhodiola. Lower CYP2D6 inhibition than paroxetine/fluoxetine - fewer supplement interactions overall
Risk
Serotonin syndrome with serotonergic supplements. Otherwise one of the cleanest SSRIs for supplement compatibility
What To Do
Avoid serotonergic supplements. Generally well-tolerated with most other supplements
Drugs.com escitalopram interactions; Lexapro FDA label
Verify → Fluoxetine - SSRI (strong CYP2D6 inhibitor) TREATS FOG HIGH
(Prozac)
CYP Metabolism
CYP2D6 (major inhibitor), CYP2C9, CYP2C19. Very long half-life (4-6 days active metabolite)
Cognitive Effect
treats depression fog
Supplement Interactions
AVOID 5-HTP, St. John's Wort, rhodiola (serotonin syndrome). Strong CYP2D6 inhibition increases levels of atomoxetine (6-8x), tamoxifen (reduces efficacy), and many other drugs. Long washout needed (5+ weeks)
Risk
CYP2D6 inhibition is the distinguishing risk - affects more supplements/drugs than other SSRIs. Extremely long half-life means interactions persist weeks after stopping
What To Do
If taking CYP2D6-dependent supplements or drugs, sertraline or escitalopram have less CYP2D6 inhibition
Drugs.com fluoxetine interactions; FDA Prozac label; PMC neuropsychiatric herb-drug interactions
Verify → Venlafaxine - SNRI TREATS FOG HIGH
(Effexor, Effexor XR)
CYP Metabolism
CYP2D6 (major), CYP3A4
Cognitive Effect
treats depression/anxiety fog
Supplement Interactions
AVOID 5-HTP (serotonin syndrome risk - Drugs.com rates as 'generally not recommended'). Melatonin (increased drowsiness/confusion). St. John's Wort (AVOID). Black pepper/piperine may inhibit CYP2D6 and increase venlafaxine side effects
Risk
Serotonin syndrome reported even at low doses of venlafaxine. CYP2D6 poor metabolizers at higher risk. Abrupt discontinuation causes severe withdrawal
What To Do
NEVER combine with 5-HTP or St. John's Wort. Melatonin OK at low doses with awareness of added drowsiness. Avoid piperine-containing supplements
Drugs.com 5-HTP + Effexor interaction; PMID 12549949 low-dose serotonin syndrome; DrugBank DB00285
Verify → Duloxetine - SNRI TREATS FOG HIGH
(Cymbalta)
CYP Metabolism
CYP1A2 (major), CYP2D6. Moderate CYP2D6 inhibitor
Cognitive Effect
treats depression/pain fog (FDA-approved for fibromyalgia, diabetic neuropathy)
Supplement Interactions
AVOID 5-HTP, St. John's Wort (serotonin syndrome). Fluvoxamine (CYP1A2 inhibition increases duloxetine 460%). Smoking cessation increases duloxetine levels 30%+ within days. Caffeine generally OK (duloxetine does not induce CYP1A2)
Risk
CYP1A2 dependence is unique among antidepressants. Smoking changes and fluvoxamine are the biggest risks. Also a moderate CYP2D6 inhibitor (affects other drugs)
What To Do
If quitting smoking, alert prescriber (dose adjustment needed). Avoid 5-HTP. St. John's Wort contraindicated
PMID 21366359; PMC11616965; FDA Cymbalta label; Drugs.com caffeine + Cymbalta
Verify → Mirtazapine - Tetracyclic antidepressant (NaSSA) MODERATE
(Remeron)
CYP Metabolism
CYP1A2, CYP2D6, CYP3A4
Cognitive Effect
can cause fog (sedation, weight gain) but treats insomnia-driven fog
Supplement Interactions
AVOID 5-HTP, St. John's Wort (serotonin syndrome). Additive sedation with valerian, kava, melatonin, L-theanine. Weight gain may be compounded by high-calorie supplements
Risk
Highly sedating - additive CNS depression with sedating supplements is the main risk. Also antihistaminic (weight gain, increased appetite)
What To Do
Take at bedtime. Avoid combining with sedating supplements. Monitor weight
Drugs.com mirtazapine interactions; FDA Remeron label
Verify → Trazodone - SARI (serotonin antagonist and reuptake inhibitor) MODERATE
(Desyrel, Oleptro)
CYP Metabolism
CYP3A4 (major)
Cognitive Effect
can cause next-day fog at higher doses
Supplement Interactions
AVOID 5-HTP, St. John's Wort (serotonin syndrome). CYP3A4 inhibitors (grapefruit, curcumin) increase levels. Additive sedation with melatonin, valerian, kava
Risk
Primarily used as sleep aid at low doses. Serotonin syndrome risk with serotonergic supplements. CYP3A4 interactions can increase sedation
What To Do
Low dose (25-50mg) for sleep has fewer interaction risks. Avoid serotonergic supplements. Grapefruit in moderation
Drugs.com trazodone interactions; FDA label
Verify → Milnacipran - SNRI (FDA-approved for fibromyalgia) TREATS FOG MODERATE
(Savella)
CYP Metabolism
Minimal CYP metabolism (renal elimination - fewer CYP interactions than other SNRIs)
Cognitive Effect
treats fibromyalgia fog
Supplement Interactions
AVOID 5-HTP, St. John's Wort (serotonin syndrome). MAOIs contraindicated. Fewer CYP-mediated interactions than duloxetine or venlafaxine
Risk
Serotonergic risk same as other SNRIs. Advantage: minimal CYP metabolism means fewer supplement interactions
What To Do
Avoid serotonergic supplements. Generally cleaner interaction profile than other SNRIs
Drugs.com milnacipran interactions; FDA Savella label
Verify → Propranolol - Non-selective beta-blocker MODERATE
(Inderal, InnoPran)
CYP Metabolism
CYP1A2 (major), CYP2D6
Cognitive Effect
can cause fog (crosses BBB, dampens norepinephrine - same mechanism as metoprolol)
Supplement Interactions
CoQ10 (may reduce side effects but also adds to hypotension). Melatonin (CYP1A2 overlap - moderate interaction). Magnesium (additive blood pressure lowering). Calcium (may reduce propranolol absorption). Ephedra/ma huang (AVOID - opposing effects)
Risk
Blood pressure lowering supplements add to hypotensive effect. CYP1A2 interactions with fluvoxamine-type supplements. Abrupt discontinuation dangerous (rebound hypertension)
What To Do
CoQ10 supplementation may help with fatigue side effects. Separate calcium 2h. Monitor blood pressure when adding supplements
Drugs.com propranolol interactions; EBSCO beta-blocker drug interactions; Drugs.com CoQ10 + propranolol
Verify → Fludrocortisone - Mineralocorticoid (POTS/orthostatic hypotension) TREATS FOG HIGH
(Florinef)
CYP Metabolism
CYP3A4
Cognitive Effect
treats POTS fog (by increasing blood volume)
Supplement Interactions
DEPLETES potassium and magnesium - supplementation typically needed. Licorice root (AVOID - synergistic potassium depletion, severe hypokalemia case reports). Salt/sodium loading (works WITH fludrocortisone - therapeutic). NSAIDs (increase fluid retention risk)
Risk
Hypokalemia is the primary risk. Licorice + fludrocortisone = dangerous synergistic potassium depletion. Potassium supplements are standard co-prescription
What To Do
Always supplement potassium when on fludrocortisone. NEVER take licorice root. Monitor electrolytes regularly. Thermotabs for combined Na/K supplementation
PoTS UK fludrocortisone guide; PMID 33391895 licorice-induced hypokalemia; Standing Up to POTS medication guide
Verify → Midodrine - Alpha-1 agonist (POTS/orthostatic hypotension) TREATS FOG MODERATE
(ProAmatine, Orvaten)
CYP Metabolism
Hepatic (prodrug activated by hydrolysis, not CYP-dependent)
Cognitive Effect
treats POTS fog (by increasing peripheral resistance)
Supplement Interactions
Alpha-agonist herbs (ephedra, yohimbe - AVOID, excessive vasoconstriction). Blood pressure-raising supplements add to effect. Fludrocortisone (complementary but monitor for supine hypertension)
Risk
Supine hypertension is the main side effect. Avoid anything that further raises blood pressure. Do not take within 4h of bedtime
What To Do
Avoid ephedra, yohimbe. Monitor supine blood pressure. Elevate head of bed 30 degrees at night
PoTS UK midodrine guide; Drugs.com midodrine interactions; Standing Up to POTS
Verify → Ivabradine - If channel inhibitor (POTS) TREATS FOG HIGH
(Corlanor)
CYP Metabolism
CYP3A4 (major)
Cognitive Effect
treats POTS fog (by reducing inappropriate tachycardia)
Supplement Interactions
CYP3A4 inhibitors (grapefruit, curcumin, quercetin) increase ivabradine levels - bradycardia risk. St. John's Wort (CYP3A4 induction - reduces levels). Heart rate-lowering supplements (magnesium high dose) additive
Risk
CYP3A4-dependent metabolism means many supplement interactions. Excessive bradycardia is the primary danger
What To Do
AVOID grapefruit and strong CYP3A4-affecting supplements. Monitor heart rate. No St. John's Wort
FDA Corlanor label; Drugs.com ivabradine interactions
Verify → Cetirizine - 2nd-gen antihistamine LOW
(Zyrtec)
CYP Metabolism
Minimal CYP metabolism (renal elimination). Mildly sedating despite being '2nd-gen'
Cognitive Effect
minimal fog (much less than diphenhydramine)
Supplement Interactions
Alcohol (increased sedation). Sedating supplements (valerian, kava, melatonin) add to drowsiness. Not affected by grapefruit. Fewer interactions than 1st-gen antihistamines
Risk
Additive sedation is the main risk. Otherwise very clean interaction profile. Can be mildly sedating in some patients
What To Do
If sedation is a concern, fexofenadine (Allegra) is least sedating. Avoid combining with alcohol or sedating supplements
ScienceDirect 2nd-gen antihistamine review; Drugs.com cetirizine interactions
Verify → Fexofenadine - 2nd-gen antihistamine (non-sedating) LOW
(Allegra)
CYP Metabolism
Not CYP-metabolized. OATP1A2 transporter substrate (unique mechanism)
Cognitive Effect
no fog (least sedating antihistamine available)
Supplement Interactions
Fruit juices (grapefruit, orange, apple) REDUCE fexofenadine absorption up to 70% via OATP1A2 inhibition. Take with water only. No significant CYP interactions. No sedation even with alcohol
Risk
Unique juice interaction - opposite of most drugs. Juices REDUCE effectiveness (not increase toxicity). No sedation risk
What To Do
Take with water, not fruit juice. Wait 4h between fexofenadine and juice. Best antihistamine choice for brain fog patients
StatPearls NBK556104; FDA grapefruit interaction notice; Medical Letter fexofenadine and fruit juice
Verify → Famotidine - H2 receptor antagonist LOW
(Pepcid)
CYP Metabolism
Minimal CYP metabolism (renal elimination)
Cognitive Effect
minimal fog (used as step-down from PPIs)
Supplement Interactions
Reduces absorption of iron, B12, calcium, magnesium, zinc (by reducing stomach acid). Less severe than PPIs. Does not significantly affect CYP enzymes
Risk
Nutrient depletion with long-term use (same mechanism as PPIs but milder). Monitor B12, iron, magnesium with chronic use
What To Do
Preferred over PPIs for long-term acid suppression. Supplement B12, iron separately (2h apart). Monitor nutrient levels annually
Drugs.com famotidine interactions; Mayo Clinic H2 blocker guidance
Verify → Cromolyn Sodium - Mast cell stabilizer TREATS FOG LOW
(Gastrocrom, NasalCrom)
CYP Metabolism
Not significantly metabolized (excreted unchanged)
Cognitive Effect
treats MCAS fog (by stabilizing mast cells)
Supplement Interactions
Virtually no drug-supplement interactions. Works locally in gut (Gastrocrom) or nasal passages (NasalCrom). Does not enter systemic circulation significantly
Risk
One of the safest medications for supplement co-administration. No CYP interactions, no absorption interference
What To Do
Safe with essentially all supplements. May be combined with quercetin and DAO enzyme for MCAS management
Drugs.com cromolyn interactions; FDA Gastrocrom label
Verify → Nystatin - Polyene antifungal (topical/oral non-absorbed) TREATS FOG LOW
(Mycostatin, Nilstat)
CYP Metabolism
Not absorbed orally - no systemic metabolism, no liver involvement
Cognitive Effect
treats candida fog (by reducing fungal overgrowth)
Supplement Interactions
Probiotics: take 2h apart (antifungal may reduce probiotic viability in gut). Otherwise virtually no interactions because nystatin is not absorbed
Risk
One of the safest antifungals. No systemic absorption = no systemic interactions. Safe with all supplements except concurrent probiotics
What To Do
Separate probiotics 2h. Otherwise no restrictions. Preferred over fluconazole for safety
NCBI LiverTox NBK548581; Drugs.com nystatin interactions
Verify → Fluconazole - Triazole antifungal (systemic) TREATS FOG HIGH
(Diflucan)
CYP Metabolism
Potent CYP2C9 inhibitor, moderate CYP3A4 inhibitor, potent CYP2C19 inhibitor. Inhibition persists 4-5 days after stopping
Cognitive Effect
treats candida fog
Supplement Interactions
Increases levels of ALL CYP2C9/3A4-metabolized supplements and drugs. Warfarin (major - INR increase). Reduces probiotic viability. Berberine, curcumin levels may be affected. Hepatotoxicity risk with concurrent hepatotoxic supplements
Risk
Potent enzyme inhibitor with long-lasting effects. Short courses (1-2 doses) are lower risk than extended treatment. Liver monitoring needed with extended use
What To Do
For short courses (single dose or 3-day), risks are lower. Extended use: monitor liver function, INR if on warfarin. Separate probiotics. Nystatin is safer alternative for mild cases
PMID 25429674; StatPearls NBK537158; Medscape fluconazole interactions
Verify → Buspirone - Azapirone anxiolytic (non-benzodiazepine) TREATS FOG MODERATE
(BuSpar)
CYP Metabolism
CYP3A4 (major)
Cognitive Effect
treats anxiety fog without sedation or dependence
Supplement Interactions
Grapefruit juice (CYP3A4 inhibition - increases buspirone levels significantly). St. John's Wort (serotonin syndrome risk - serotonergic properties). 5-HTP (additive serotonergic risk). CYP3A4-affecting supplements alter levels
Risk
CYP3A4-dependent - grapefruit is the most clinically significant interaction. Serotonin syndrome possible but lower risk than with SSRIs
What To Do
Avoid grapefruit. Avoid 5-HTP and St. John's Wort. Otherwise a clean anxiolytic with no dependence risk
Drugs.com buspirone interactions; FDA BuSpar label
Verify → Hydroxyzine - Antihistamine anxiolytic CAUSES FOG MODERATE
(Vistaril, Atarax)
CYP Metabolism
CYP2D6, CYP3A4
Cognitive Effect
causes fog (antihistamine sedation, short-term use preferred)
Supplement Interactions
Additive sedation with melatonin, valerian, kava, L-theanine. Anticholinergic properties - may compound with other anticholinergic supplements. Alcohol (additive CNS depression)
Risk
Sedation is the primary interaction risk. Anticholinergic burden in combination with other anticholinergic agents
What To Do
Short-term use only for acute anxiety. Buspirone for chronic anxiety. Avoid combining with sedating supplements
Drugs.com hydroxyzine interactions; FDA label
Verify → Lamotrigine - Anticonvulsant / mood stabilizer HIGH
(Lamictal)
CYP Metabolism
UGT glucuronidation (NOT CYP-dependent). Estrogen induces glucuronidation
Cognitive Effect
generally cognitive-neutral (better than valproate/topiramate for cognition)
Supplement Interactions
Oral contraceptives (estrogen reduces lamotrigine levels ~50% - dose adjustment needed). Valproate (inhibits glucuronidation - doubles lamotrigine levels). Folic acid supplementation recommended for women of childbearing age
Risk
Hormonal fluctuations directly affect lamotrigine levels. Starting/stopping oral contraceptives requires dose adjustment. Stevens-Johnson syndrome risk with rapid dose changes
What To Do
Adjust dose when starting/stopping hormonal contraception. Supplement folic acid. Avoid rapid dose changes. One of the most cognitive-friendly mood stabilizers
FDA Lamictal label; Neurology valproate/lamotrigine/OC study; MGH Women's Mental Health lamotrigine-OC FAQ
Verify → Valproate / Valproic Acid - Anticonvulsant / mood stabilizer CAUSES FOG HIGH
(Depakote, Depakene)
CYP Metabolism
CYP2C9, CYP2C19, UGT glucuronidation. Inhibits multiple CYP enzymes
Cognitive Effect
causes fog (cognitive dulling, tremor, weight gain common)
Supplement Interactions
Carbapenems (AVOID - dramatically reduce valproate levels). Folic acid (depleted by valproate - supplement recommended). L-carnitine (valproate depletes carnitine, especially in children). Aspirin/NSAIDs (increase free valproate levels). Lamotrigine (doubles lamotrigine levels)
Risk
Teratogenic (pregnancy category X). Hepatotoxic. Depletes folic acid and carnitine. Multiple significant drug interactions
What To Do
Supplement folic acid (especially childbearing age). Consider L-carnitine supplementation. Monitor liver function. Lamotrigine is a less cognitively impairing alternative for bipolar maintenance
GoodRx valproate interactions; FDA Depakote label; Drugs.com valproate interactions
Verify → Lithium - Mood stabilizer (alkali metal) AVOID
(Lithobid, Eskalith)
CYP Metabolism
Not metabolized (100% renal elimination). Levels controlled by sodium/water balance
Cognitive Effect
can cause fog (cognitive dulling, tremor, thyroid suppression)
Supplement Interactions
Sodium (decreased intake raises lithium levels; increased intake lowers levels). NSAIDs/ibuprofen (increase lithium 10-400%). ACE inhibitors (increase lithium up to 400%). Diuretics/thiazides (increase lithium 25-400%). Caffeine withdrawal (increases lithium 24%). Potassium-sparing diuretics. Electrolyte supplements ALTER lithium handling
Risk
NARROW therapeutic index - small changes cause toxicity (tremor, confusion, seizures, death). Sodium, NSAIDs, ACE inhibitors, and diuretics are the most dangerous interactions. Caffeine changes also significant
What To Do
NEVER change sodium intake, start NSAIDs, or change diuretics without lithium level monitoring. Avoid ibuprofen (use acetaminophen). Keep caffeine intake CONSISTENT. Monitor lithium levels with any medication or supplement change
PMC7358048; GoodRx 7 lithium interactions; PMID 8521679; PMID 2258452; Medsafe NZ lithium guidance
Verify → Low-Dose Naltrexone (LDN) - Opioid antagonist (immunomodulator at low dose) TREATS FOG HIGH
(Compounded (1.5-4.5mg). Full-dose: ReVia, Vivitrol)
CYP Metabolism
CYP3A4 (minor). Mainly hepatic reduction to 6-beta-naltrexol
Cognitive Effect
treats fog (autoimmune/neuroinflammation - used in fibro, MS, long COVID, MCAS)
Supplement Interactions
AVOID all opioid-containing supplements and medications (blocks opioid receptors - precipitates withdrawal). Sedating supplements (valerian, kava, melatonin) may increase drowsiness. Most other supplements are safe. May reduce thyroid medication need as autoimmune activity decreases - monitor TSH
Risk
ABSOLUTE contraindication with any opioid (including tramadol, codeine, opioid cough syrups). At LDN doses (1.5-4.5mg), side effects are generally mild (vivid dreams, transient headache). Therapeutic window is narrow - above 4.5mg loses immunomodulatory benefit
What To Do
Confirm zero opioid use before starting. Start at 1.5mg at bedtime, titrate slowly. Monitor thyroid if Hashimoto's. Take at bedtime (endorphin rebound occurs during sleep)
PMC6313374 (LDN therapeutic review); PMC7528597 (LDN and thyroid hormones); PMID 29885638 (immune-related diseases)
Verify → Warfarin - Vitamin K antagonist anticoagulant AVOID
(Coumadin, Jantoven)
CYP Metabolism
CYP2C9 (major), CYP3A4, CYP1A2. NARROW therapeutic index
Cognitive Effect
neutral (prevents stroke - protects cognition indirectly)
Supplement Interactions
Vitamin K (directly opposes warfarin - keep intake consistent, don't eliminate). CoQ10 (structurally similar to vitamin K - case reports of reduced INR). Fish oil >3g/day (additive bleeding). Cranberry juice (CYP2C9 inhibition - case reports including fatality). Curcumin (INR rose >10 in case report). Ginkgo (additive bleeding). St. John's Wort (CYP induction - reduces warfarin levels). Garlic, ginger (mild antiplatelet)
Risk
Most dangerous supplement interaction profile of any common medication. Narrow therapeutic index means small changes cause either clotting (stroke) or bleeding (hemorrhage). EVERY supplement change requires INR monitoring
What To Do
Discuss EVERY new supplement with anticoagulation clinic before starting. Monitor INR within 1 week of any supplement change. Keep vitamin K intake consistent, not zero
Br J Clin Pharmacol Tan 2021 systematic review; PMC3534595 (cardiovascular supplement interactions); UC San Diego warfarin supplement guide
Verify → Ketamine / Esketamine - NMDA receptor antagonist (dissociative anesthetic/antidepressant) PRO-COGNITIVE MODERATE
(Spravato (esketamine nasal); IV ketamine (compounded))
CYP Metabolism
CYP2B6 (major), CYP3A4
Cognitive Effect
pro-cognitive (treats treatment-resistant depression; rapid onset)
Supplement Interactions
St. John's Wort (CYP3A4 induction - reduces ketamine levels). Benzodiazepines may diminish antidepressant effect. No clinically significant interactions with standard antidepressants per FDA. CYP3A4 inhibitors (grapefruit, curcumin) may increase ketamine exposure but FDA says dose adjustment not warranted
Risk
Relatively clean interaction profile at clinical doses. Main risks are additive dissociation/sedation with CNS depressants, and blood pressure elevation
What To Do
Avoid St. John's Wort. Benzodiazepines before treatment may reduce efficacy. Most supplements are safe. Administered in clinical setting (Spravato) reduces interaction risk
J Clin Psychiatry ketamine drug interactions review; JNJ SPRAVATO drug interactions; Br J Clin Pharmacol Langmia 2022 pharmacogenetics
Verify → Spironolactone - Potassium-sparing diuretic / antiandrogen HIGH
(Aldactone)
CYP Metabolism
Hepatic (thioether formation, not significantly CYP-dependent)
Cognitive Effect
neutral (used for PCOS, acne, heart failure)
Supplement Interactions
Potassium supplements (AVOID - hyperkalemia risk, can cause cardiac arrest). ACE inhibitors + potassium + spironolactone = dangerous combination (K+ rose 1.2 mmol/L in studies). Licorice root (opposes aldosterone blockade). Electrolyte supplements need careful potassium monitoring
Risk
Hyperkalemia is the primary lethal risk. Any additional potassium source (supplements, salt substitutes, electrolyte drinks with potassium) can be dangerous
What To Do
NEVER take potassium supplements without medical supervision. Monitor electrolytes regularly. Avoid potassium-containing salt substitutes. Check electrolyte drink labels for potassium content
PMC4955086 (electrolyte disturbance with diuretics/ACEi); Drugs.com spironolactone interactions
Verify → Amoxicillin - Penicillin antibiotic LOW
(Amoxil, Augmentin (with clavulanate))
CYP Metabolism
Minimal CYP metabolism (renal elimination)
Cognitive Effect
neutral (treats infection)
Supplement Interactions
Probiotics (separate 2h - antibiotic kills probiotic organisms). Oral contraceptives (possible reduced effectiveness - use backup). Fewer mineral chelation issues than tetracyclines. Methotrexate (reduced renal clearance - increased toxicity)
Risk
Generally one of the safest antibiotics for supplement co-administration. Main consideration is probiotic timing and completing the full course
What To Do
Take probiotics 2h after amoxicillin. Continue probiotics for 2 weeks after finishing course. Can take with food to reduce GI upset
Drugs.com amoxicillin interactions; FDA label
Verify → Tizanidine - Alpha-2 adrenergic agonist (muscle relaxant) CAUSES FOG HIGH
(Zanaflex)
CYP Metabolism
CYP1A2 (major - critical interaction pathway)
Cognitive Effect
causes fog (sedation, muscle relaxation)
Supplement Interactions
CYP1A2 inhibitors dramatically increase tizanidine levels (fluvoxamine increases AUC 33-fold). Caffeine withdrawal may increase levels. Additive sedation with melatonin, valerian, kava. Additive blood pressure lowering with magnesium, L-theanine
Risk
CYP1A2-dependent metabolism makes this extremely sensitive to enzyme inhibitors. Excessive sedation and hypotension are the main dangers
What To Do
Avoid CYP1A2-inhibiting supplements. Keep caffeine intake consistent. Take at bedtime when possible. Baclofen is an alternative with different metabolism
FDA Zanaflex label (CYP1A2 interaction warning); Drugs.com tizanidine interactions
Verify → Montelukast - Leukotriene receptor antagonist LOW
(Singulair)
CYP Metabolism
CYP2C8, CYP3A4
Cognitive Effect
can cause fog (FDA boxed warning: neuropsychiatric events including confusion, depression, suicidal ideation)
Supplement Interactions
Few significant supplement interactions. St. John's Wort (CYP3A4 induction may reduce levels). Generally safe with most supplements
Risk
FDA boxed warning for neuropsychiatric events (depression, suicidal thoughts, agitation) - not a supplement interaction but important context for brain fog patients
What To Do
Monitor mood closely. Report any neuropsychiatric symptoms immediately. Intranasal steroids are alternatives for allergic rhinitis
FDA Singulair boxed warning (March 2020); Drugs.com montelukast interactions
Verify →A Note on Statins
Recent large-scale evidence has shifted the consensus - statins are now considered potentially neuroprotective. They should not be discontinued for cognitive concerns without discussing with your prescriber.
Frequently Asked Questions
Which supplements are dangerous with SSRIs?
5-HTP, St. John's Wort, and rhodiola should be avoided with any SSRI due to serotonin syndrome risk. Serotonin syndrome is rare but serious and can be life-threatening. Omega-3, magnesium, and vitamin D are generally safe with SSRIs. Always verify with your pharmacist before adding any supplement to an SSRI.
Can I take supplements with blood thinners like warfarin?
Warfarin has the most dangerous supplement interaction profile of any common medication. Vitamin K directly opposes it, CoQ10 may reduce its effect, and supplements like ginkgo, curcumin, fish oil (>3g/day), and cranberry juice can increase bleeding risk. Keep vitamin K intake consistent (don't eliminate it) and check INR within 1 week of any supplement change.
Does metformin deplete vitamin B12?
Yes. Metformin impairs B12 absorption through the intrinsic factor pathway. A meta-analysis found B12 levels reduced by an average of 57 pmol/L after 4 months. The MHRA recommends monitoring B12 in all metformin patients. Combined metformin + PPI use dramatically increases deficiency risk. Use sublingual methylcobalamin to bypass the absorption issue.
What medications cause brain fog as a side effect?
The most common fog-causing medications include anticholinergics (diphenhydramine, oxybutynin, amitriptyline), benzodiazepines (alprazolam, lorazepam), Z-drugs (zolpidem), topiramate ("Dopamax"), opioids, gabapentin/pregabalin, PPIs (via B12 depletion), and lipophilic beta-blockers (metoprolol). Alternatives exist for most - discuss with your prescriber. Do not stop medications without medical guidance.
Are there any pro-cognitive medications?
Vortioxetine (Trintellix) is the only antidepressant with RCT evidence for cognitive improvement independent of mood. Bupropion (Wellbutrin) causes less cognitive blunting than SSRIs due to its norepinephrine-dopamine mechanism. Modafinil promotes wakefulness and is used off-label for MS and chemo fog. These are prescription medications - discuss with your doctor if your current medication is causing fog.
Not medical advice. Consult your pharmacist and physician.
Related Causes
Drug interaction pages should route to medication and psych overlap causes.